Cyprinid Herpesvirus 2: Goldfish Hematopoietic Necrosis
Overview and Taxonomy of Cyprinid Herpesvirus 2: Goldfish Hematopoietic Necrosis
Taxonomic Classification and Phylogenetic Position
Cyprinid herpesvirus 2 (CyHV-2), the etiological agent of herpesviral hematopoietic necrosis disease (HVHND), occupies a defined taxonomic position within the family Alloherpesviridae, a lineage of herpesviruses that exclusively infect fish and amphibians. Within this family, CyHV-2 is assigned to the genus Cyprinivirus, a clade that includes other significant cyprinid pathogens: cyprinid herpesvirus 1 (CyHV-1, the agent of carp pox) and cyprinid herpesvirus 3 (CyHV-3, the causative agent of koi herpesvirus disease) [5, 6, 8, 9]. The genus Cyprinivirus also encompasses the closely related Carassius auratus herpesvirus (CaHV) and, more distantly, Anguillid herpesvirus 1 (AngHV-1) from eels [8]. This taxonomic framework is critical for understanding the evolutionary relationships and pathogenic mechanisms shared among these viruses, as they all target cyprinid hosts but induce markedly different disease syndromes.
The International Committee on Taxonomy of Viruses (ICTV) recognizes CyHV-2 as a distinct species, and its classification is supported by comprehensive genomic analyses. The complete genome of the reference strain, CyHV-2 ST-J1, is a linear double-stranded DNA molecule of approximately 290,428 base pairs, with a characteristic structure that includes terminal repeat (TR) regions at both ends [8, 14]. The genome is predicted to encode between 150 and 154 open reading frames (ORFs), depending on the strain and the annotation methodology employed [8, 13, 14]. This substantial coding capacity underscores the virus's ability to modulate host cellular machinery and evade immune responses, a hallmark of herpesviruses across vertebrate hosts.
Genomic Architecture and Genetic Diversity
The genomic organization of CyHV-2 is complex and exhibits significant collinearity with other cypriniviruses, yet it possesses unique features that distinguish it from CyHV-1 and CyHV-3. Comparative genomics have revealed that while CyHV-2 shares a high degree of collinearity with other CyHV-2 isolates, there are notable variations in locally collinear blocks (LCBs) when compared to CyHV-1 and CyHV-3, and the lowest degree of collinearity is observed with AngHV-1, confirming their evolutionary divergence [8]. The genome is characterized by the presence of terminal repeat regions, although strain YC-01, isolated from gibel carp, notably lacks these TRs, indicating intraspecific genomic plasticity [14].
The genetic diversity among CyHV-2 isolates is not merely academic; it has practical implications for virulence, host range, and diagnostic accuracy. High-resolution proteogenomic analyses using mass spectrometry have refined our understanding of the CyHV-2 coding landscape. A landmark study employing proteogenomic mapping confirmed the expression of 117 previously annotated ORFs and, critically, identified 12 novel ORFs (designated nORF1-12) that were previously unannotated [13]. One of these novel proteins, nORF1 (also termed ORF25E), is a phosphorylated protein that serves as a prospective molecular marker for tracing the evolutionary trajectory of CyHV-2 from the Japanese (J) genotype to the Chinese (C) genotype [13]. This finding is of paramount importance for epidemiological surveillance, as it allows researchers to track the spread and adaptation of distinct viral lineages across geographic regions. Additional genomic characterization of strains such as SH-01 and YC-01 has identified specific genetic markers, including ORF107 and ORF156 as potential molecular markers for strain YC-01, and ORF55 (encoding thymidine kinase) as a potential discriminator between the YC-01/ST-J1 lineage and other CyHV-2 isolates [8, 14].
Host Range and Species Specificity
CyHV-2 is primarily recognized as a pathogen of fish within the genus Carassius, with goldfish (Carassius auratus) and crucian carp (Carassius carassius and Carassius auratus gibelio) considered the principal susceptible species [4, 6, 9, 31]. The virus causes herpesviral hematopoietic necrosis disease (HVHND), a condition characterized by severe necrosis of hematopoietic tissues, particularly in the kidney and spleen, leading to high morbidity and mortality [2, 11, 17]. However, the host range of CyHV-2 is broader than initially appreciated. Experimental infection studies have demonstrated that CyHV-2 can infect and cause mortality in silver carp (Hypophthalmichthys molitrix), with kidney-derived inocula inducing up to 80% mortality [5]. Furthermore, surveillance studies have detected CyHV-2 DNA in apparently healthy common carp (Cyprinus carpio) reared in cage culture, identifying this species as an asymptomatic carrier [18, 35]. This finding challenges the long-held assumption of strict species specificity and raises significant concerns for disease management, as common carp co-cultured with goldfish or crucian carp may serve as a cryptic reservoir for viral transmission.
The ability of CyHV-2 to infect non-carassid species is supported by molecular evidence from multiple geographic regions. In Poland, CyHV-2 was detected in ornamental goldfish varieties (Veiltail, Wakin, Red Cap Oranda, and Ranchu) imported from Thailand and the UK, and simultaneously in asymptomatic common carp from neighboring cages [18]. Similarly, a study in Korea detected CyHV-2 exclusively in imported goldfish from Thailand, with the marker A region showing distinct repetitive sequence sizes compared to isolates from China, France, Poland, and Israel [21]. This geographical and host-associated genetic variation suggests that CyHV-2 is continuously evolving and adapting, potentially expanding its host range under the pressures of global trade and aquaculture intensification. The World Organisation for Animal Health (WOAH) recognizes the economic threat posed by CyHV-2, and the Food and Agriculture Organization (FAO) has highlighted the need for enhanced surveillance and biosecurity measures to prevent the further dissemination of this pathogen in aquaculture systems worldwide.
Clinical Disease and Pathogenesis
The hallmark of CyHV-2 infection is herpesviral hematopoietic necrosis, a disease that targets the kidney, spleen, and gill tissues, leading to profound pathological changes. Clinically affected fish exhibit lethargy, anorexia, pale gills, and a severely enlarged and softened spleen and kidney, often accompanied by a reddened liver [2, 11, 31]. Histopathological examination reveals extensive necrosis of hematopoietic tissue, with the kidney showing a preponderance of cells exhibiting peripherally displaced chromatin, a classic cytopathic effect indicative of herpesviral infection [2, 11]. Transmission electron microscopy (TEM) has confirmed the presence of herpesvirus particles within the cytoplasm and nucleus of infected cells, consistent with the assembly and egress of a large, enveloped DNA virus [11, 33].
The pathogenesis of CyHV-2 is driven by its ability to establish both lytic and latent infections. Following primary infection, the virus replicates to high titers in the kidney and spleen, with viral loads reaching up to 107.8 TCID50/mL in cell culture isolates [1, 3, 10]. However, a defining feature of CyHV-2, shared with other herpesviruses, is its capacity to establish lifelong latency in surviving fish. Virus DNA has been detected in the spleen, trunk kidney, and gills of asymptomatic survivors for up to 81 days post-infection, and infectious virus could be recovered from kidney homogenates after in vitro incubation [17]. Crucially, latency is maintained in monocytes and macrophages, as demonstrated by the detection of viral DNA in isolated monocytes from the trunk kidney of asymptomatic survivors [7]. This cellular tropism for professional phagocytes is a strategic adaptation that allows the virus to evade immune clearance while remaining poised for reactivation.
Reactivation of latent CyHV-2 can be triggered by immunosuppression or environmental stress. Experimental administration of dexamethasone (Dex) and cyclosporine A (CsA) led to a significant increase in viral DNA levels in the kidney and spleen of asymptomatic carriers, with the combined treatment yielding the greatest reactivation [7]. The mechanism involves suppression of interferon gamma (IFNγ) production by T-helper 1 (Th1) cells, which in turn reduces the antiviral activity of monocytes and macrophages [7]. This finding is corroborated by in vitro studies showing that recombinant IFNγ supplementation reduces viral DNA in kidney leukocyte cultures [7]. In the field, temperature stress has been identified as a potent trigger for reactivation. In one study, raising water temperature from 3–6°C to 25°C in apparently healthy goldfish with prior CyHV-2 exposure resulted in the isolation of infectious virus (strain YZ01) [33]. Similarly, CyHV-2 reactivation was observed in gibel carp following temperature stress, with increased viral DNA copy numbers and gene transcription detected in multiple tissues [28]. These observations have profound implications for aquaculture management, as environmental fluctuations, particularly rapid temperature changes, can precipitate disease outbreaks in previously stable populations.
Molecular Mechanisms of Immune Evasion and Pathogenesis
CyHV-2 has evolved a sophisticated arsenal of immune evasion strategies that enable it to subvert host antiviral defenses, particularly the interferon (IFN) response. A critical mechanism involves the ORF67 protein, which directly inhibits IFN expression by binding to TBK1-A/B and competitively blocking the phosphorylation of STING-A/B [12]. This interference with the STING-TBK1 signaling axis effectively dismantles the host's first line of antiviral defense, allowing the virus to establish productive infection without triggering a robust IFN response. The identification of this mechanism is a significant advance, as it provides a molecular target for the development of antiviral therapies and attenuated vaccines.
Another immune evasion strategy employed by CyHV-2 is the expression of a viral tumor necrosis factor receptor (vTNFR) homolog, encoded by ORF4. This protein, a homolog of herpesvirus entry mediator (HVEM), is a secreted factor that localizes to the cytoplasm of infected cells and enhances viral propagation [24]. ORF4 promotes cell proliferation and suppresses CyHV-2-induced apoptosis, thereby facilitating viral replication [24]. The virus also manipulates host microRNA (miRNA) networks to its advantage. For instance, miR-124, which is upregulated during infection, targets and suppresses the expression of the pro-apoptotic protein ccBax. By inhibiting apoptosis, miR-124 promotes viral replication, as demonstrated by the fact that transfection of miR-124 mimics enhances CyHV-2 replication, while inhibitors suppress it [16]. This represents a sophisticated viral strategy to co-opt host regulatory pathways to create a more permissive cellular environment.
Furthermore, CyHV-2 encodes a complex repertoire of proteins that modulate host cell signaling. Phosphoproteomic analyses have revealed that CyHV-2 infection induces widespread phosphorylation changes in the host proteome, particularly affecting proteins involved in RNA processing, translation, cytoskeleton organization, and immune signaling [19]. The virus itself produces 11 phosphorylated viral proteins during infection, and its ORF88 and ORF89 proteins interact with host kinases such as casein kinase II (CK-II) and cyclin-dependent kinase (CDK), which are potential targets for therapeutic intervention [19]. Transcriptomic and proteomic studies have consistently shown that CyHV-2 activates the PI3K-AKT signaling pathway while suppressing the p53 signaling pathway [23, 27]. This shift promotes cell survival and metabolism, creating an environment conducive to viral replication. The perturbation of these pathways is evident in the differential expression of thousands of host genes, with the IL-17 signaling pathway, glutathione metabolism, and neuroactive ligand-receptor interaction pathways being significantly enriched in infected fish [25].
Latency and Reactivation: A Persistent Challenge
The ability of CyHV-2 to establish and maintain latency is perhaps its most insidious feature from a disease management perspective. Latency is characterized by the persistence of viral genomic DNA in the absence of active viral gene transcription. In gibel carp that survived primary infection, CyHV-2 DNA was detectable in multiple tissues at 300 days post-infection, but active transcription of genes such as DNA polymerase and ORF99 was absent [28]. This quiescent state can be reversed by environmental or physiological stressors. As noted, temperature stress is a potent reactivation trigger, but chemical inducers such as trichostatin A (TSA) and phorbol 12-myristate 13-acetate (TPA) can also reactivate virus from a latently infected brain cell line (GCBLat1) derived from CyHV-2-exposed fish [28]. This in vitro model provides a valuable tool for studying the molecular switches that govern the latent-to-lytic transition.
The clinical relevance of latency is profound. Asymptomatic carriers, which may appear healthy for extended periods, represent a reservoir for viral shedding and transmission. In one study, four out of five asymptomatic survivors tested positive for CyHV-2 DNA in the kidney and spleen, and inoculation of naïve fish with homogenate from these tissues resulted in mortality [17]. This demonstrates that the virus remains infectious even during latency, and that stress-induced reactivation can lead to disease in the carrier itself or in cohabiting susceptible fish. The findings from WOAH and FAO guidelines emphasize the need for quarantine and screening of apparently healthy fish prior to introduction into naive populations, as undetected carriers can precipitate outbreaks under the stress of transportation and temperature change.
Diagnostic Considerations for Taxonomy and Surveillance
The accurate identification and taxonomic classification of CyHV-2 rely on a suite of molecular and immunological tools. PCR targeting the DNA polymerase gene and the major capsid protein (MCP) gene remains the gold standard for detection, with assays capable of detecting as few as 10–100 copies of viral DNA [26, 34]. However, the field has seen rapid advancement in point-of-care diagnostics, including recombinase polymerase amplification (RPA) coupled with lateral flow dipsticks (LFD). These assays can detect CyHV-2 within 20–30 minutes at a constant temperature of 36–38°C, with a detection limit of 102 gene copies per reaction and no cross-reactivity with related viruses such as CyHV-3, spring viremia of carp virus (SVCV), or infectious spleen and kidney necrosis virus (ISKNV) [4, 32]. More recently, a one-pot recombinase-aided amplification (RAA) CRISPR/Cas12a system has been developed, capable of detecting as few as 10 copies of CyHV-2 within 60 minutes, and can be combined with iron flocculation for direct detection in aquaculture water samples without the need for fish dissection [15]. These innovations are critical for field surveillance and early outbreak detection.
Immunological detection methods, including monoclonal antibodies (MAbs) against structural proteins such as ORF66, ORF92, and ORF25, have been developed for immunohistochemistry and neutralization assays [20, 22, 29, 30]. MAbs targeting the ORF25 membrane protein have demonstrated titer-dependent neutralization of CyHV-2 in vitro and can be used for immunodiagnosis in fish tissues [29]. The development of these tools not only aids in diagnosis but also facilitates studies on viral protein function and pathogenesis, contributing to our understanding of the taxonomic characteristics of CyHV-2 within the Alloherpesviridae family.
The global distribution and genetic diversity of CyHV-2 underscore the importance of continued surveillance. Strains have been isolated from China, Japan, Korea, Poland, India, and the United States, with genetic analyses revealing at least two major genotypes (J and C) that can be distinguished by markers such as the mA region and nORF1 [13, 18, 21]. The introduction of CyHV-2 into previously naive regions, often through the international ornamental fish trade, highlights the need for stringent biosecurity protocols aligned with WOAH and FAO recommendations. The detection of CyHV-2 in asymptomatic carriers of multiple cyprinid species, including species not traditionally considered susceptible, underscores the virus's adaptability and the need for a comprehensive, multi-species surveillance approach.
Molecular Pathogenesis of CyHV-2: Mechanisms of Hematopoietic Tissue Necrosis
The molecular pathogenesis of cyprinid herpesvirus 2 (CyHV-2) represents a complex, multi-layered interplay between viral evasion strategies, host cellular subversion, and the targeted destruction of hematopoietic tissues. The hallmark of herpesviral hematopoietic necrosis disease (HVHND) is the profound and selective necrosis of the kidney and spleen, the primary hematopoietic organs in cyprinids [2, 6, 9]. Understanding the precise molecular mechanisms driving this tissue-specific tropism and lytic destruction is critical for developing rational therapeutic and prophylactic interventions. The virus, a member of the genus Cyprinivirus within the family Alloherpesviridae, possesses a large double-stranded DNA genome of approximately 275–290 kbp, encoding over 150 open reading frames (ORFs) [8, 13, 14]. This genomic complexity endows CyHV-2 with a sophisticated arsenal of proteins that manipulate host cell signaling, suppress innate immunity, and ultimately trigger the apoptotic and necrotic pathways that define the disease.
Viral Entry, Tropism, and the Establishment of Infection in Hematopoietic Tissues
The pathogenesis of HVHND begins with viral entry, likely through the gills and skin, followed by rapid hematogenous dissemination to target organs [11]. The kidney and spleen are the primary sites of viral replication, a tropism that is not merely incidental but is driven by the specific expression of host cell receptors and the permissive environment provided by hematopoietic progenitor cells and monocytes/macrophages. Source [7] provides compelling evidence that monocytes/macrophages isolated from the trunk kidney of asymptomatic survivors harbor persistent CyHV-2 DNA, identifying these cells as major reservoirs for both latent and reactivated infection. This cellular tropism is a cornerstone of pathogenesis; the virus does not simply infect any cell but specifically targets the very cells responsible for the host's immune defense and erythropoiesis. The viral membrane proteins, particularly those encoded by ORF25 and its variants (ORF25C, ORF25D), are critical for this process. These proteins are major immunogens and are essential for viral entry and cell-to-cell spread [29, 38, 42]. The identification of ORF25 as a potent antigen that induces high antibody titers and provides significant protective immunity (up to 70% relative percent survival in DNA vaccine studies) underscores its central role in the initial stages of infection [38]. Furthermore, the successful display of truncated ORF25, ORF25C, and ORF146 on baculovirus surfaces for immersion vaccination, achieving relative percentage survival values of 83.3%, 87.5%, and 70.8% respectively, confirms that these membrane glycoproteins are critical for host cell recognition and are viable targets for vaccine development [42].
Once inside the host cell, the virus initiates a temporally regulated gene expression cascade. The immediate-early (IE) genes, identified as ORF54, ORF121, ORF141, ORF147, and ORF155, are transcribed immediately upon viral entry and do not require de novo viral protein synthesis [41]. These IE gene products are the master regulators of the infection cycle, acting to transactivate early (E) and late (L) gene expression while simultaneously subverting host antiviral responses. The early genes, including the DNA polymerase gene used extensively for molecular detection [2, 11, 34], are responsible for viral genome replication. The late genes encode structural proteins, such as the major capsid protein (MCP, ORF92) and other tegument and envelope components, which are assembled into progeny virions [30, 37]. The massive production of viral progeny within hematopoietic cells leads to cellular dysfunction and, ultimately, cell death. The virus titer in the kidney of experimentally infected goldfish can reach (10^{3.47}) to (10^{3.59}) copies/mg, a level of replication that is unsustainable for normal tissue function [6].
Subversion of Host Antiviral Signaling: The Interferon Axis
A critical determinant of CyHV-2 pathogenicity is its ability to evade the host's type I interferon (IFN) response, a first line of antiviral defense in teleosts. The virus has evolved multiple, redundant mechanisms to dismantle this pathway. A landmark study by Cui et al. [12] elucidated a sophisticated immune evasion strategy mediated by the viral protein ORF67. This protein directly binds to the host kinases TBK1-A/B, which are essential for the phosphorylation and activation of STING-A/B, a central adaptor in the cytosolic DNA-sensing pathway. By competitively blocking STING phosphorylation, ORF67 effectively prevents the downstream activation of interferon regulatory factors (IRFs) and the subsequent transcription of IFN genes. This mechanism is a classic example of viral mimicry and interference, where a viral protein acts as a dominant-negative inhibitor of a critical host signaling node. The consequence is a profound suppression of the IFN response, allowing the virus to replicate unchecked during the critical early stages of infection. This finding is supported by broader transcriptomic and proteomic analyses, which consistently show that the RIG-I-like receptor (RLR) signaling pathway and the downstream IFN-stimulated gene (ISG) response are activated but ultimately overwhelmed during CyHV-2 infection [27, 40]. The virus does not merely avoid the IFN response; it actively dismantles it.
Further subversion occurs at the level of viral gene expression regulation. The virus encodes its own set of microRNAs (miRNAs), which are small non-coding RNAs that post-transcriptionally regulate gene expression. Source [40] identified ten viral miRNAs that are significantly modulated during CyHV-2 infection in GiCF cells. One of these, CyHV-2-KT-635, was shown to target and downregulate the expression of the viral ORF121 protein, an IE gene product. While the functional significance of this self-regulation is not fully understood, it is hypothesized that such viral miRNAs may fine-tune the temporal expression of viral genes, potentially facilitating the establishment of latency or modulating the host immune response. The host cell's own miRNA machinery is also hijacked. Source [16] demonstrated that host miR-124 directly targets and suppresses the expression of ccBax, a pro-apoptotic member of the Bcl-2 family. By downregulating ccBax, miR-124 inhibits CyHV-2-induced apoptosis, thereby preventing the premature death of the host cell and allowing for more efficient viral replication. This represents a remarkable example of the virus exploiting a host regulatory mechanism to promote its own propagation.
Manipulation of Host Cell Survival and Death Pathways: Apoptosis and Necrosis
The ultimate outcome of CyHV-2 infection in hematopoietic tissues is necrosis, but the molecular journey to this endpoint is a highly regulated battle between pro- and anti-apoptotic signals. The virus actively manipulates host cell survival pathways to create a favorable environment for replication. Transcriptomic and proteomic studies have revealed that the PI3K-AKT signaling pathway, a central regulator of cell survival and metabolism, is activated during CyHV-2 infection [23]. This activation likely promotes cell survival and provides the metabolic resources necessary for viral genome replication and virion assembly. Conversely, the p53 signaling pathway, a key tumor suppressor and inducer of apoptosis, is suppressed [23, 27]. This dual manipulation, activating survival signals while blocking death signals, allows the virus to maintain the host cell in a viable, metabolically active state for as long as possible.
However, the virus also encodes its own death-modulating proteins. Source [24] identified ORF4 as a secreted homolog of the tumor necrosis factor receptor (TNFR) superfamily, specifically a homolog of the herpesvirus entry mediator (HVEM). This viral TNFR (vTNFR) is a secreted protein that can bind to host TNF family ligands, acting as a decoy receptor to neutralize the host's cytotoxic TNF response. Overexpression of ORF4 enhanced viral propagation, while its knockdown suppressed viral replication and promoted CyHV-2-induced apoptosis. This suggests that ORF4 functions to delay or prevent apoptosis, allowing the virus to complete its replication cycle. The balance between pro- and anti-apoptotic signals is delicate. Ultimately, the massive viral load and the cumulative cellular stress trigger cell death. The observation of apoptosis in GiCF cells upon CyHV-2 infection, characterized by DAPI staining, TUNEL assays, and activation of caspase genes, confirms that apoptosis is a component of the host response [43]. However, the extensive tissue necrosis observed in vivo suggests that in the later stages of infection, the cell death machinery is overwhelmed, leading to uncontrolled lytic necrosis. The downregulation of proteins involved in phagocytosis, such as NCF2 and NCF4, as identified in transcriptomic/proteomic analyses [27], may impair the clearance of apoptotic bodies, leading to secondary necrosis and the release of pro-inflammatory cellular contents, which exacerbates tissue damage.
Latency, Reactivation, and the Role of Monocytes/Macrophages
A defining feature of all herpesviruses is their ability to establish lifelong latent infections, and CyHV-2 is no exception. The virus can persist in asymptomatic survivors, serving as a reservoir for future outbreaks [17, 28]. The molecular mechanisms governing latency and reactivation are central to the long-term pathogenesis of HVHND. Source [7] provides critical insights, demonstrating that monocytes/macrophages in the trunk kidney are the primary sites of viral persistence. In these cells, the viral genome is maintained in a quiescent state with minimal gene expression. Reactivation can be triggered by immunosuppression or stress. The study showed that injection of dexamethasone (Dex), a potent immunosuppressant that inhibits monocyte/macrophage function, led to a significant increase in viral DNA levels in survivors [7]. Similarly, cyclosporine A (CsA), which inhibits T-helper 1 (Th1) cells and consequently IFNγ production, also promoted reactivation, particularly when combined with Dex. This indicates that the host's immune surveillance, particularly IFNγ-mediated activation of monocytes/macrophages, is crucial for maintaining viral latency. The addition of recombinant IFNγ to kidney leukocyte cultures from survivors reduced viral DNA levels, directly demonstrating the role of this cytokine in controlling latent infection [7].
This model of latency and reactivation is further supported by in vitro studies. Source [28] established a cell line (GCBLat1) from the brain tissue of CyHV-2-exposed fish that harbored the viral genome but did not produce infectious virions under normal culture conditions. However, treatment with trichostatin A (TSA), a histone deacetylase inhibitor, or phorbol 12-myristate 13-acetate (TPA), a protein kinase C activator, successfully reactivated the virus, leading to viral gene transcription and production of infectious particles. This demonstrates that the latent genome is maintained in a chromatinized state and that epigenetic modifications play a key role in regulating the switch between latency and lytic replication. The ability of CyHV-2 to persist in monocytes/macrophages is particularly insidious. These cells are mobile and can traffic throughout the body, disseminating the virus to new tissues and to naïve hosts. Furthermore, the stress of transport, temperature fluctuations, or co-infection with bacterial pathogens like Aeromonas spp. [5, 36] can trigger reactivation, leading to clinical disease and mortality even in previously healthy carrier fish. The detection of CyHV-2 in asymptomatic common carp (Cyprinus carpio) reared in cage culture alongside diseased goldfish [18] underscores the potential for cross-species transmission and the role of asymptomatic carriers in the epizootiology of the disease.
The Final Common Pathway: Hematopoietic Tissue Necrosis
The culmination of these molecular events is the massive necrosis of hematopoietic tissue. The histopathological hallmark of HVHND is the presence of severely enlarged and softened spleen and kidney, with microscopic examination revealing severe necrosis of the hematopoietic parenchyma [2, 6, 11]. The nuclei of affected cells often exhibit peripherally displaced chromatin, a classic sign of apoptosis, but the overall tissue architecture is one of lytic necrosis [2]. The molecular pathogenesis is a cascade: (1) viral entry and replication in monocytes/macrophages and hematopoietic progenitors; (2) subversion of the IFN response via ORF67 and other mechanisms, allowing unchecked viral spread; (3) manipulation of host cell survival pathways (PI3K-AKT activation, p53 suppression) to create a permissive environment; (4) expression of viral anti-apoptotic factors like ORF4 (vTNFR) and exploitation of host miRNAs like miR-124 to delay cell death; (5) eventual overwhelming of these defenses by the massive viral burden, leading to mitochondrial dysfunction, activation of caspases, and initiation of apoptosis; and (6) failure of phagocytic clearance due to downregulation of key phagocytosis genes, resulting in secondary necrosis and the release of damage-associated molecular patterns (DAMPs) that amplify inflammation and tissue destruction. The net effect is the rapid and near-complete obliteration of the hematopoietic tissue, leading to severe anemia, immunosuppression, and multi-organ failure, culminating in the high mortality rates (often exceeding 80% in naïve populations) that characterize HVHND [1, 3, 6]. The identification of specific viral proteins, such as ORF88 and ORF89, which interact with host kinases like casein kinase II (CK-II) and cyclin-dependent kinase (CDK) [19], and the development of monoclonal antibodies against key structural and non-structural proteins (e.g., ORF66, ORF92, ORF121) [22, 30, 39] provide the molecular tools to further dissect these pathways. The ongoing proteogenomic re-annotation of the CyHV-2 genome, which has already identified 12 novel ORFs [13], promises to reveal even more sophisticated mechanisms of pathogenesis, offering new targets for antiviral drugs and vaccine development.
Epidemiology and Transmission Dynamics of CyHV-2 in Goldfish Populations
Global Distribution and Host Range
Cyprinid herpesvirus 2 (CyHV-2) has emerged as a globally significant pathogen of ornamental and food-fish aquaculture, with a documented distribution that now spans Asia, Europe, and beyond. The virus was first isolated from cultured goldfish in Japan, where it was identified as the etiological agent of herpesviral hematopoietic necrosis (HVHN) [9]. Since its initial characterization, CyHV-2 has been confirmed in goldfish populations across East Asia, including Korea [2] and multiple provinces in China [11, 31]. In Korea, diagnostic investigations revealed CyHV-2 in goldfish experiencing epizootics during April and June 2014, with molecular analysis of the DNA polymerase gene demonstrating 100% identity with previously deposited sequences [2]. Similarly, outbreaks in Beijing ornamental fish farms during 2018 were linked to CyHV-2, with the polymerase gene product sharing 99.10% nucleotide sequence identity with published sequences [11].
The geographic range of CyHV-2 extends well beyond Asia. In Europe, the virus was first documented in Poland, where mass mortalities of ornamental goldfish varieties, including Veiltail, Wakin, Red Cap Oranda, and Ranchu, occurred in cage culture systems receiving post-cooling water from a power plant [18]. Sequence analysis of the 295-bp mA marker from these Polish isolates (designated RSD-PL, GenBank KX852452.1) revealed greatest similarity to the AMS-8 and FR types previously identified in diseased fish imported from Israel and Asia, respectively [18]. Surveillance efforts in West Bengal, India, further confirmed the presence of CyHV-2 in both apparently healthy and diseased goldfish between December 2014 and March 2015, emphasizing that the virus is endemic in regions with intensive ornamental fish production [36]. The World Organisation for Animal Health (WOAH) recognizes CyHV-2 as a pathogen of economic significance, and its international spread via the ornamental fish trade represents a critical pathway for continued geographic expansion.
The host range of CyHV-2 has traditionally been considered restricted to species within the genus Carassius, including goldfish (Carassius auratus), crucian carp (Carassius carassius), and gibel/Prussian carp (Carassius gibelio). However, emerging evidence challenges this strict species specificity. Experimental infection studies have demonstrated that CyHV-2 can infect common carp (Cyprinus carpio), with molecular detection in blood, gills, and pooled organ samples from asymptomatic individuals co-habitating with diseased goldfish in Polish cage culture facilities [18]. This finding has profound epidemiological implications, as common carp may serve as undetected reservoirs facilitating viral persistence and dissemination. More provocatively, recent investigations detected CyHV-2 DNA in koi carp and tilapia following experimental infection, with survival rates of 70% and 30%, respectively, at 20 days post-infection [35]. The same study identified CyHV-2 DNA in samples from grass carp and revealed a newly discovered herpesvirus (tentatively CyHV-5) in grass carp, further suggesting that the diversity and host range of cyprinid herpesviruses may be substantially underestimated [35]. These findings align with WOAH and FAO concerns regarding the role of subclinical carriers in transboundary aquatic animal disease spread.
Within the genus Carassius, susceptibility to CyHV-2 appears to extend across diverse ornamental varieties and commercial strains. The pathogen has been documented in fantail, Veiltail, Wakin, Red Cap Oranda, and Ranchu goldfish varieties [18], as well as in color crucian carp [31] and gibel carp [14, 46]. Comparative challenge studies using the CyHV-2 SH01 strain, isolated from crucian carp, demonstrated rapid and fatal disease progression in both goldfish and crucian carp within 24 hours post-injection at 28°C, with average virus titers in goldfish kidney reaching 10³.⁴⁷ to 10³.⁵⁹ copies/mg [6]. Histopathological changes including cellular wrinkling, cytoplasmic vacuolation, fusion of gill lamellae, and hepatic congestion were consistent across both species, confirming the high sensitivity of Carassius spp. to CyHV-2 infection [6].
Transmission Pathways and Environmental Stability
The mechanisms of CyHV-2 transmission are multifaceted, involving direct horizontal transmission, waterborne spread, and potentially fomite-mediated dissemination. Horizontal transmission is considered the primary route, occurring through contact with infected individuals or exposure to virus-contaminated water. The virus is shed in high concentrations from infected fish, particularly through renal and branchial routes, as these tissues exhibit the most pronounced pathology and highest viral loads. Experimental infection trials using tissue-derived inocula have demonstrated differential pathogenicity depending on the source tissue: kidney-derived inocula induced up to 80% mortality, gill-derived inocula 70%, and liver-derived inocula only 10%, highlighting the kidney and gill as critical targets for viral replication and shedding [5].
Waterborne transmission is particularly relevant in aquaculture settings, where high stocking densities and recirculating water systems facilitate rapid viral spread. The detection of CyHV-2 in aquacultural waters has been enabled by novel concentration and detection technologies, such as iron flocculation combined with RAA-CRISPR/Cas12a assays, which can detect as few as 10 copies of viral DNA per reaction in environmental samples [15]. This methodological advance underscores the feasibility of environmental surveillance for early outbreak detection. While direct studies on CyHV-2 stability in water are limited, comparative research on the closely related cyprinid herpesvirus 3 (CyHV-3) provides useful insights. CyHV-3 maintains infectivity for extended periods in sterile water samples (≤1 log reduction after 96 hours) but is inactivated more rapidly in unsterile environmental water, with up to five log reductions within 96 hours correlating with increasing bacterial load [47]. By extension, CyHV-2 likely exhibits similar environmental persistence, remaining infectious for sufficient periods to facilitate transmission within and between facilities.
The role of fomites and mechanical vectors in CyHV-2 transmission cannot be overlooked. The virus has been detected in apparently healthy common carp cohabitating with infected goldfish, suggesting that non-target species can acquire and potentially translocate the virus on their body surfaces or within their gastrointestinal tracts [18]. The ornamental fish trade, involving international shipments of goldfish and crucian carp, represents a well-documented pathway for transboundary spread. Imported goldfish from Thailand to Korea were found to carry CyHV-2, with genetic characterization of the marker A region revealing distinct repetitive sequence sizes compared to isolates from China, France, Poland, and Israel [21]. The Food and Agriculture Organization (FAO) has highlighted the ornamental fish trade as a major driver of emerging aquatic disease distribution, and the detection of CyHV-2 in multiple imported consignments reinforces the need for robust pre-export and post-import quarantine protocols.
Latency, Reactivation, and the Role of Asymptomatic Carriers
One of the most epidemiologically significant features of CyHV-2 is its capacity to establish persistent, latent infections in asymptomatic carrier fish. Following primary infection and clinical recovery, surviving goldfish harbor viral DNA in multiple organs, particularly the spleen and trunk kidney, for extended periods. Virus DNA has been detected in all tested organs at 51 days post-infection, and in the spleen, trunk kidney, and gills of survivors at 81 days post-infection [17]. Importantly, in vitro culture of PCR-positive kidney tissue from asymptomatic survivors demonstrated that the detected viral DNA corresponded to infectious particles capable of causing mortality in naïve fish following inoculation [17]. This establishes that recovered fish are not merely carrying viral genomic remnants but harbor replication-competent virus with transmission potential.
The cellular reservoir for CyHV-2 latency has been identified as monocytes/macrophages. Virus DNA was detected in monocytes isolated from the trunk kidney of asymptomatic survivors, suggesting that these cells serve as the primary site of persistent infection [7]. This cellular tropism is particularly relevant for transmission dynamics, as monocytes are mobile cells capable of trafficking throughout the host and potentially shedding virus into the environment. The establishment of latency in monocyte/macrophage lineages mirrors strategies employed by other herpesviruses, including CyHV-3, and represents a sophisticated immune evasion mechanism that allows the virus to persist in populations even after apparent clearance of acute infection.
Reactivation of latent CyHV-2 can be triggered by immunosuppression, temperature stress, and pharmacologic agents. Experimental administration of dexamethasone, a synthetic corticosteroid with potent immunosuppressive properties, resulted in significant increases in viral DNA levels at 10 and 21 days post-injection in asymptomatic survivors [7]. Cyclosporine A, an inhibitor of T-helper 1 (Th1) cells, also induced virus reactivation, particularly when combined with dexamethasone, which synergistically suppressed monocyte/macrophage function and antibody production [7]. The recombinant interferon-γ (IFNγ) supplementation in kidney leukocyte cultures from survivors reduced viral DNA levels, indicating that IFNγ-mediated immune surveillance is critical for maintaining latency [7]. Temperature stress also serves as a potent reactivation stimulus. In fish recovered from primary infection, raising water temperature from 3–6°C to 25°C resulted in virus reactivation, with increased CyHV-2 DNA copy numbers and gene transcription observed in multiple tissues [28, 33]. The CyHV-2 strain YZ01 was isolated from apparently healthy goldfish following such temperature elevation, confirming that environmental thermal shifts can trigger recrudescent infections [33].
The epidemiological implications of latency and reactivation are profound. Asymptomatic carriers function as cryptic reservoirs that can intermittently shed infectious virus into the environment, particularly during periods of stress associated with transport, temperature fluctuation, or co-infection. This phenomenon likely explains the seasonal pattern of CyHV-2 outbreaks, which occur predominantly in spring and autumn when water temperatures range between 15°C and 28°C, conditions that encompass both the optimal temperature for viral replication and the thermal stress that may trigger reactivation [11]. Moreover, the detection of CyHV-2 in apparently healthy goldfish during routine surveillance in West Bengal [36] and Poland [18] underscores that subclinical infections are common and represent a continuous source of viral introduction into naive populations.
Risk Factors and Transmission Drivers
Environmental and management factors profoundly influence CyHV-2 transmission dynamics. Water temperature is arguably the most critical determinant, as it directly affects viral replication kinetics, host immune competence, and the probability of reactivation from latency. The optimal temperature range for CyHV-2 replication is between 15°C and 28°C, corresponding to the spring and autumn periods when most outbreaks are reported [11]. Experimental infection studies have demonstrated that the live attenuated vaccine strain P7-P8 grows effectively between 15°C and 30°C in goldfish cell lines, with protective efficacy ranging from 73.3% at 15°C to 100% at 25°C after subsequent virulent challenge [48]. The highest vaccine virus load in the spleen was observed at 25°C (10⁶.⁵ DNA copies/mg), while the lowest was at 15°C (10³.⁷ copies/mg), suggesting that a threshold of approximately 10⁴ DNA copies/mg may be required to elicit sufficient acquired immunity [48]. These temperature-dependent dynamics have direct implications for transmission: at permissive temperatures, viral replication is robust, shedding is likely increased, and the probability of transmission to cohabitating fish is maximized. Conversely, at non-permissive high temperatures, viral replication is restricted, leading to the clearance of acute infection and establishment of latency [45].
Co-infections with bacterial pathogens significantly exacerbate CyHV-2-associated mortality and may facilitate transmission by compromising host immune defenses. Bacteriological analysis of CyHV-2 outbreaks in Indian carp polyculture systems revealed concomitant infections with Aeromonas spp., suggesting viral-bacterial synergism during disease outbreaks [5]. Similarly, surveillance of CyHV-2-infected goldfish in West Bengal identified co-infection with members of the bacterial genera Aeromonas and Flavobacterium in kidney tissues [36]. The immunosuppressive effects of CyHV-2 infection, particularly the disruption of hematopoietic tissue and the downregulation of immune pathways, likely predispose fish to secondary bacterial infections, which in turn increase morbidity and mortality, thereby amplifying viral shedding and transmission.
Host genetics and selective breeding also influence population-level susceptibility and transmission. Inheritance studies have demonstrated that resistance to HVHN in goldfish follows a Mendelian dominant inheritance pattern. Progeny from parents that survived CyHV-2 infection exhibited increased resistance, leading to the establishment of a resistant Azumanishiki variety strain in Saitama Fisheries Research Institute, Japan [44]. Crosses between resistant Azumanishiki and susceptible Kurodemekin varieties produced F₁ offspring with intermediate resistance, and subsequent breeding through F₂ and F₃ generations successfully yielded resistant pop-eyed Kurodemekin [44]. These findings have profound implications for transmission dynamics: the introduction of resistant genotypes into susceptible populations could reduce overall viral replication and shedding, thereby lowering the basic reproductive number (R₀) of CyHV-2 in aquaculture settings. Conversely, the widespread use of susceptible varieties may sustain high transmission rates and facilitate viral persistence.
Genomic Diversity and Strain Variation
The genomic characterization of CyHV-2 isolates from diverse geographic regions has revealed substantial genetic diversity that may influence transmission dynamics, virulence, and host range. The complete genome of the SH-01 strain, isolated from crucian carp in Shanghai, comprises 290,428 bp with 154 potential open reading frames and terminal repeat regions at both ends [8]. Comparative genomics demonstrated that SH-01 shares 99.60% identity with the ST-J1 strain but exhibits nucleotide mutations, deletions, insertions, and gene duplications compared to other CyHV-2 isolates [8]. The YC-01 strain, isolated from gibel carp in Jiangsu Province, possesses a genome of 275,367 bp without terminal repeat regions and 151 potential ORFs, with particular variations in the orientation and position of ORF25 and ORF25B [14].
Phylogenetic analyses have classified CyHV-2 isolates into distinct genotypes, with the identification of ORF107 and ORF156 as potential molecular genetic markers for differentiating strains [14]. Notably, the novel phosphorylated open reading frame nORF1 (also designated ORF25E) has been proposed as a prospective molecular marker capable of monitoring evolutionary transitions from the Japan (J) genotype to the China (C) genotype of CyHV-2 [13]. The C genotype, represented by strains such as CNDF-TB2015 and SY-C1, appears to be more closely related to the YZ01 strain isolated from goldfish following temperature-induced reactivation [33]. The functional significance of these genotypic differences remains to be fully elucidated, but variations in membrane protein-encoding genes, particularly ORF25, are likely to influence viral entry, cell tropism, and immune evasion. ORF25 and its truncated forms have been identified as major immunogenic proteins and promising vaccine candidates [29, 37, 42], suggesting that strain-specific variation in these proteins could impact both pathogenesis and the efficacy of control measures.
The detection of novel, unannotated ORFs through proteogenomic analysis, including 12 novel ORFs designated nORF1-12, indicates that the coding capacity of CyHV-2 is more extensive than previously recognized [13]. These novel ORFs may encode proteins that modulate host immune responses or enhance viral transmission. For example, ORF67 of CyHV-2 has been shown to inhibit interferon expression by competitively blocking STING phosphorylation, thereby facilitating immune evasion and potentially increasing viral shedding [12]. Similarly, the virus-encoded tumor necrosis factor receptor homolog ORF4 enhances viral propagation and promotes host cell proliferation while suppressing apoptosis [24], mechanisms that likely contribute to efficient viral replication and transmission. Understanding the functional diversity of CyHV-2 genes across strains will be essential for predicting transmission potential and designing targeted intervention strategies.
Clinical Signs and Histopathological Features of Herpesviral Hematopoietic Necrosis Disease
Herpesviral hematopoietic necrosis disease (HVHND), caused by cyprinid herpesvirus 2 (CyHV-2), represents one of the most economically devastating viral infections affecting ornamental and food-fish aquaculture within the genus Carassius. The disease is officially listed by the World Organisation for Animal Health (WOAH) as a significant pathogen of goldfish and crucian carp, reflecting its capacity to induce rapid, high-mortality epizootics. The clinical presentation and underlying histopathological alterations are remarkably consistent across goldfish (Carassius auratus), gibel carp (Carassius auratus gibelio), and crucian carp (Carassius carassius), though subtle variations exist depending on viral strain, host genetics, and environmental conditions, particularly water temperature. A comprehensive understanding of these features is essential for accurate field diagnosis, differentiation from other cyprinid pathogens, and the development of effective control strategies.
Clinical Manifestations: From Prodrome to Terminal Collapse
The clinical course of HVHND is typically acute to peracute, with mortality often commencing within 24 to 48 hours post-exposure at permissive temperatures (15–28°C) [1, 6, 11]. The initial prodromal phase is subtle and easily overlooked. Affected goldfish exhibit progressive lethargy, often congregating near the water surface or at the margins of the culture vessel, displaying pronounced anoxic behavior characterized by opercular flaring and labored respiration [2, 5, 31]. These behavioral changes are accompanied by complete inappetence, which rapidly leads to emaciation in prolonged cases.
As the disease progresses, the external clinical signs become more pronounced and pathognomonic. The most consistent and striking external feature is severe pallor of the gills, which transition from a healthy, vibrant red to a pale, almost translucent pink or grayish-white [2, 11, 36]. This pallor is a direct macroscopic reflection of the profound anemia induced by the destruction of hematopoietic and renal tissues. Concurrently, the skin may exhibit focal or diffuse hemorrhagic lesions, particularly on the flanks, operculum, and base of the fins, although these are less consistently reported and may reflect secondary bacterial involvement, such as co-infection with Aeromonas spp. [5, 36]. In some epizootics, affected fish present with exophthalmia (pop-eye) and a visibly distended coelomic cavity due to ascites, though these signs are more variable [31, 44]. Moribund fish often lose their equilibrium, displaying spiral or erratic swimming patterns before sinking to the bottom, where they eventually succumb.
Crucially, external lesions are not universally present. Several outbreaks, particularly those involving highly virulent isolates or rapid disease progression, may proceed to mass mortality with no obvious external clinical signs beyond lethargy and pallor [1, 9]. This subtlety of external presentation underscores the critical importance of internal gross pathology and histopathology for definitive diagnosis. The disease is strictly seasonal, with outbreaks peaking in spring and autumn when water temperatures fluctuate within the permissive range, and mass mortality events can exceed 80–100% in naïve, susceptible populations [1, 3, 11].
Gross Internal Pathology: The Hallmarks of Hematopoietic Destruction
Upon necropsy, the internal gross lesions are striking and highly diagnostic. The spleen and trunk kidney are the primary target organs and exhibit the most dramatic alterations. Both organs are consistently found to be severely enlarged (splenomegaly and nephromegaly) and markedly softened, often to the point of being friable and almost liquefied [2, 9, 11]. The normal turgor is lost, and the organs may appear congested or hemorrhagic on cut surface. This degeneration is the macroscopic correlate of the extensive necrosis that defines the disease histologically.
The liver frequently presents as pale, mottled, or frankly congested, sometimes described as a "red liver" due to widespread congestion and hepatic sinusoidal dilation [2, 6]. The gills, aside from their pallor, may show evidence of focal necrosis or lamellar fusion upon close inspection with a dissecting microscope [31]. In some cases, particularly during peracute death, the gills may simply appear edematous. The gastrointestinal tract is often devoid of food, and ascitic fluid may be present in the peritoneal cavity. Petechial hemorrhages may be observed on the serosal surfaces of the visceral organs and the peritoneum, reflecting the underlying systemic vasculitis and coagulopathy [5, 9]. The heart and pancreas can also display multifocal necrotic foci, though these are less prominent than the changes in the hematopoietic tissues [31].
Histopathological Features: A Systematic Dissection of Cellular Destruction
The histopathological lesions of HVHND are definitive and allow for a conclusive diagnosis. The signature lesion is a severe, multifocal to diffuse necrosis of the hematopoietic tissue in the kidney and spleen [2, 6, 11, 31].
Renal and Splenic Pathology
In the kidney, the interrenal hematopoietic parenchyma is the primary target. The normal architecture is obliterated by extensive areas of coagulative necrosis, characterized by pyknotic and karyorrhectic nuclear debris interspersed with anuclear, eosinophilic cellular ghosts. Within these necrotic foci, the most pathognomonic cellular hallmark is the presence of large, swollen cells with eccentric, peripherally displaced chromatin. These cells, often described as having a "marginated" or "ballooned" nucleus, are frequently identified in the kidney and are highly suggestive of CyHV-2 infection [2]. They represent cells undergoing cytopathic degeneration with intranuclear viral replication. Renal tubular epithelium may also undergo degeneration and necrosis, but the hematopoietic tissue is the principal target. Intranuclear inclusion bodies, typical of herpesvirus infections, are less consistently observed in goldfish compared to some other cyprinid herpesviruses but have been reported in some outbreaks [6, 31].
The spleen mirrors the renal pathology. The splenic ellipsoids and red pulp, rich in macrophages and lymphocytes, undergo widespread necrosis. The white pulp is depleted of lymphocytes, and the normal lymphoid architecture collapses. Melano-macrophage centers, normally a distinct feature of the fish spleen, may become disrupted and infiltrated with necrotic debris.
Gill Pathology
Gill lesions are a consistent and critical component of the histopathology, though often secondary in severity to the hematopoietic necrosis. The primary and secondary lamellae exhibit severe hyperplasia and fusion, leading to a marked reduction in the respiratory surface area and contributing to the observed anoxia and respiratory distress [6, 11, 36]. Lamellar epithelial cells may become necrotic and slough into the interlamellar spaces. In acutely affected fish, widespread lamellar epithelial lifting and edema of the gill filament are observed. The same characteristic margination of nuclear chromatin seen in the kidney can occasionally be observed in gill epithelial cells [2].
Hepatic, Pancreatic, and Cardiac Lesions
The liver typically displays severe congestion and sinusoidal dilation, often accompanied by focal or multi-focal coagulative necrosis of hepatocytes [6, 31]. Hepatic cells may exhibit cytoplasmic vacuolation, cellular wrinkling, and shrinkage, reflecting metabolic stress and hypoxia. The exocrine pancreas, often embedded within the hepatic and splenic tissues, can exhibit focal necrosis, a finding that can help differentiate HVHND from other viral infections [31]. The heart may also show multifocal necrotic foci within the myocardium, especially in severe systemic infections [31].
Inflammatory Infiltrates and Viral Inclusions
Given the immune-suppressive nature of the virus, the inflammatory response in the affected tissues is often surprisingly mild relative to the severity of the necrosis. However, a mixed inflammatory infiltrate comprising macrophages, lymphocytes, and occasional granulocytes can be found at the margins of necrotic foci [36]. In chronic or recovery phases, these infiltrates become more pronounced.
Intranuclear inclusion bodies, while not a universal finding, are considered diagnostic when present. These are typically eosinophilic (Cowdry type A) inclusions that displace the host cell chromatin to the periphery. They have been documented in the kidney, gill, spleen, and pancreas of affected goldfish and crucian carp [6, 31]. The detection of these inclusions is highly dependent on the sampling time and the viral strain.
Ultrastructural Features and Pathophysiological Correlation
Transmission electron microscopy (TEM) of affected tissues reveals the presence of icosahedral herpesvirus virions within the nucleus and cytoplasm of degenerating cells [11, 33, 43]. Viral particles measure approximately 170–200 nm in diameter and are composed of an electron-dense core surrounded by a capsid, often with an outer envelope visible in mature particles. Masses of viral particles are frequently seen in the nucleus, forming paracrystalline arrays, and in the cytoplasm by budding through the nuclear membrane.
The clinical signs of lethargy and pallor are a direct consequence of the destruction of the hematopoietic tissue in the kidney and spleen. This leads to a severe reduction in circulating red blood cells (anemia) and white blood cells (leukopenia), compromising oxygen transport and the host's ability to mount an effective immune response. The gill necrosis and lamellar fusion exacerbate the hypoxic state, creating a positive feedback loop of tissue damage and dysfunction. The observed hemorrhages are likely due to a combination of thrombocytopenia (from hematopoietic destruction), endothelial damage from viral replication, and the development of a consumptive coagulopathy.
Pathological Mechanisms: Virus-Driven Cytopathology and Immune Evasion
The severe histopathology is not merely a passive result of viral replication. CyHV-2 actively subverts host cellular machinery to facilitate its own propagation. The virus encodes proteins such as ORF67, which competitively blocks the phosphorylation of STING, a critical adaptor in the interferon (IFN) signaling pathway, thereby suppressing the host's innate antiviral response [12]. This immune evasion strategy allows for unchecked viral replication within the hematopoietic tissues. Similarly, the viral ORF4 encodes a tumor necrosis factor receptor (vTNFR) homolog that promotes cell proliferation and inhibits apoptosis, facilitating viral persistence and spread [24].
Paradoxically, the virus also induces apoptosis in a carefully regulated manner. The host microRNA miR-124 targets the pro-apoptotic gene ccBax, thereby suppressing apoptosis and promoting viral replication [16]. This suggests a complex interplay between viral and host factors where the virus manipulates cell death pathways to its advantage.
Differential Diagnosis and the Role of Co-infections
The clinical signs and histopathology of HVHND must be differentiated from other diseases presenting with anemia and hematopoietic necrosis, such as Cyprinid herpesvirus 1 (CyHV-1) causing carp pox, which presents with epidermal hyperplasia rather than severe hematopoietic necrosis, and Cyprinid herpesvirus 3 (CyHV-3) causing koi herpesvirus disease (KHVD), which primarily targets the gills and skin with characteristic branchitis [9, 49]. Co-infections with bacterial pathogens like Aeromonas hydrophila are common and can complicate the pathological picture, leading to more severe and protracted clinical signs [5, 36]. The presence of CyHV-2 as the primary etiological agent should be confirmed by PCR or in situ hybridization, as the histopathological features, while highly suggestive, are not entirely pathognomonic when co-infections are present.
Latency and Reactivation: A Histopathological Ghost
A critical aspect of the disease is the ability of CyHV-2 to establish lifelong latency in surviving fish, particularly within the monocytes/macrophages of the trunk kidney and spleen [7, 17, 28]. Clinically, these carriers appear asymptomatic, and tissues may show no active histopathological lesions. However, viral genomic DNA persists, and the virus can be reactivated under stress, such as temperature fluctuations or immunosuppression (e.g., via dexamethasone or cyclosporine A) [7, 28]. Upon reactivation, a recrudescence of clinical signs and histopathological lesions identical to the primary infection can occur, leading to renewed shedding and horizontal transmission. This latency mechanism explains the cyclical nature of outbreaks in endemic populations and underscores the difficulty of eradication. The histopathology in these recovered carriers is often unremarkable, but the presence of viral DNA in the absence of active lesions is a hallmark of the carrier state, identifiable only through molecular diagnostics [17].
Diagnostic Approaches for CyHV-2: Molecular, Serological, and Cell Culture Methods
The accurate and timely diagnosis of cyprinid herpesvirus 2 (CyHV-2) is paramount for managing herpesviral hematopoietic necrosis disease (HVHND) in goldfish, crucian carp, and gibel carp. The diagnostic landscape for this pathogen has evolved considerably, driven by the need for high sensitivity to detect subclinical carriers, specificity to differentiate it from other cyprinid herpesviruses, and practicality for both laboratory and field-based surveillance. A comprehensive diagnostic strategy integrates molecular assays for direct pathogen detection, serological techniques for monitoring immune responses and latent infections, and cell culture systems for virus isolation, propagation, and characterization. Each modality presents distinct advantages and limitations, and their combined application is critical for a robust understanding of CyHV-2 epidemiology and pathogenesis.
Molecular Diagnostics: From Conventional PCR to Isothermal and CRISPR-Based Platforms
Molecular detection of CyHV-2 genetic material forms the cornerstone of contemporary diagnostics, offering unparalleled sensitivity and specificity for direct pathogen identification. The most established and widely deployed method is the polymerase chain reaction (PCR). Numerous studies have demonstrated the efficacy of conventional PCR targeting conserved regions of the CyHV-2 genome, most frequently the DNA polymerase gene [2, 11, 14] and the major capsid protein (MCP) gene [4, 34]. These assays have been instrumental in confirming the etiology of disease outbreaks across diverse geographic regions including Korea [2], China [11, 31], India [5, 36], and Poland [18]. The diagnostic power of PCR lies in its ability to detect viral DNA not only in clinically diseased fish with high viral loads but also in asymptomatic carriers, a critical feature given the propensity of CyHV-2 to establish persistent and latent infections [7, 17]. For instance, PCR-based surveillance detected CyHV-2 DNA in apparently healthy common carp (Cyprinus carpio) reared in cage culture alongside infected goldfish, revealing a previously unrecognized asymptomatic vector species and challenging the strict host-specificity dogma [18]. Similarly, PCR screening of multiple goldfish varieties during a mortality event in Poland confirmed the presence of a novel CyHV-2 genotype (RSD-PL) [18].
Real-time quantitative PCR (qPCR) has further refined molecular detection by providing absolute quantification of viral genome copies, enabling the assessment of viral load dynamics and the distinction between active replication and residual latency. Using qPCR targeting the polymerase gene, researchers quantified viral titers in tissues of experimentally infected goldfish, observing peak loads of up to (10^{3.59}) copies/mg in the kidney [6]. This quantitative capacity is invaluable for evaluating the efficacy of antiviral compounds, such as berberine and star anise extracts, which demonstrably reduce viral copy numbers in both in vitro and in vivo models [51, 55]. Furthermore, qPCR has been utilized to monitor vaccine virus replication, demonstrating that a threshold of approximately (10^4) DNA copies/mg in the spleen is necessary to elicit robust protective immunity following live attenuated vaccination [48].
While PCR and qPCR remain the gold standard, their reliance on thermocyclers and relatively long run times has spurred the development of isothermal amplification techniques for point-of-care (POC) and field-deployable diagnostics. Loop-mediated isothermal amplification (LAMP) has emerged as a robust alternative. A LAMP assay targeting the MCP gene demonstrated superior sensitivity compared to conventional PCR, detecting as few as 10 copies of a plasmid construct versus 100 copies for PCR, while maintaining 100% specificity against a panel of other fish pathogens [34]. Another LAMP assay combined with a lateral flow dipstick (LFD) for visual readout achieved a detection limit of 0.18 pg/μL of total DNA within 60 minutes at 64°C, requiring only a simple water bath or heat block [26].
The recombinase polymerase amplification (RPA) assay represents the next generation of isothermal technology, amplifying DNA within 15-30 minutes at a constant low temperature (~37-38°C), eliminating the need for any specialized heating equipment. The coupling of RPA with LFD has proven exceptionally powerful. A landmark study developed the first RPA-LFD for CyHV-2 targeting the MCP gene, achieving a detection limit of (10^2) gene copies per reaction in 20 minutes at 36°C, with no cross-reactivity against CyHV-3, spring viremia of carp virus (SVCV), or other significant pathogens [4]. A subsequent RPA-LFD assay targeting the ORF72 gene proved 100 times more sensitive than routine PCR, taking less than 50 minutes from sample to result [32]. This technology is ideally suited for resource-limited settings and on-farm diagnosis, enabling rapid intervention to prevent further spread.
The most recent and perhaps most revolutionary innovation in CyHV-2 molecular detection is the integration of isothermal amplification with CRISPR/Cas12a systems. A novel "one-pot RAA-CRISPR/Cas12a" assay was developed by combining recombinase-aided amplification (RAA) with the Cas12a endonuclease. This platform detects as few as 10 copies of the CyHV-2 genome per reaction within 60 minutes, showcasing sensitivity comparable to or exceeding qPCR [15]. Crucially, when applied to clinical samples, this method demonstrated a higher positive detection rate than conventional PCR, likely due to its ability to cleave any non-target amplicon, reducing background and increasing signal-to-noise ratio [15]. When combined with iron flocculation technology for concentrating virus from aquaculture water samples, this system offers a non-invasive, sentinel-based surveillance approach, minimizing fish sacrifice and maximizing detection efficiency [15]. The emergence of such technologies underscores a paradigm shift towards rapid, highly sensitive, and field-accessible molecular diagnostics that align with World Organisation for Animal Health (WOAH) principles for efficient disease control and surveillance in aquatic animal health.
Serological Diagnostics: Monoclonal Antibodies and Immunological Assays
While molecular methods detect the virus itself, serological approaches provide critical complementary information about the host's exposure history and immune status. The development of specific monoclonal antibodies (MAbs) has been pivotal for immunological detection and for functional studies of CyHV-2 proteins. The first generation of CyHV-2-specific MAbs was generated by immunizing mice with purified whole virus, yielding six MAbs that bound to distinct proteins, including ORF88, ORF55R, ORF115, and ORF151R. These MAbs specifically detected CyHV-2 in infected cell cultures by immunofluorescence (IFA) and, importantly, exhibited in vitro neutralizing activity, with MAb 2E1-B10 showing the most potent effect in attenuating cytopathic effect (CPE) [20]. This demonstrated the potential for MAbs not only as diagnostic tools but also as therapeutic or prophylactic reagents.
Subsequent efforts have focused on generating MAbs against specific, immunodominant viral proteins for targeted diagnostic applications. MAbs against the major capsid protein ORF92 were among the first to be developed. The resulting MAb 1B7 specifically identified CyHV-2 in infected RyuF-2 cells and in gill, kidney, and spleen tissues by Western blotting and IFA, proving its utility for immunohistochemical detection of viral antigen in formalin-fixed tissues [30]. Similarly, a MAb against the capsid-related protein ORF66 (MAb 2F11) was successfully applied to detect virus particles in infected cell lines and in tissue sections from infected gibel carp [22]. The membrane protein ORF25, a major immunogen and a candidate for vaccine development, has been a key target. Five MAbs against recombinant ORF25 were generated, and one (2C3-1E6) was successfully used in ELISA, IFA, and immunohistochemistry to detect CyHV-2 in infected cells and fish tissues. Furthermore, this MAb exhibited a titer-dependent neutralization effect in vitro, confirming ORF25 as a target for neutralizing antibodies [29]. A MAb against the immediate-early protein ORF121 (MAb 3D9) also showed neutralizing activity and was effective for detecting CyHV-2 in GiCF cells and in gill, kidney, and spleen tissues by both IFA and immunohistology [39].
Beyond direct viral antigen detection, serological assays are crucial for quantifying humoral immune responses, particularly in the context of vaccine efficacy evaluation. Enzyme-linked immunosorbent assays (ELISA) have been developed to measure anti-CyHV-2 IgM antibody titers in goldfish and gibel carp plasma. Using whole CyHV-2 virus or recombinant proteins (e.g., ORF132) as coating antigens, these assays have demonstrated significant antibody production following both injection and immersion vaccination with live attenuated [45, 50] and oral yeast-based vaccines [46, 52]. However, the correlation between antibody titer and protection is not always absolute. For example, in goldfish vaccinated with the P7-P8 live attenuated strain, high survival rates (88-100%) were observed despite relatively low and variable antibody levels, strongly suggesting that cell-mediated immunity, driven by CD8α+ cytotoxic T lymphocytes, is the primary correlate of protection in this system [45, 48]. This highlights a critical nuance: while serological tools are excellent for confirming exposure and the induction of adaptive immunity, they alone may not be sufficient to predict protective efficacy, particularly for vaccines that primarily elicit a cellular response. The use of these immunological tools, including Western blot analysis for detecting specific viral proteins, aligns with standard virological practices recommended for confirmation of viral infections by reference laboratories.
Cell Culture and Virus Isolation: The Foundational Platform for Diagnostics and Research
Despite the ascendancy of molecular diagnostics, cell culture remains an indispensable tool for CyHV-2 research and diagnostics. The ability to isolate and propagate the virus in permissive cell lines is essential for confirming infectivity, obtaining high-titer viral stocks for experimental studies, producing antigens for serological assays and vaccines, and studying viral biology, including replication kinetics, cytopathology, and latency. The initial breakthrough was the establishment of the RyuF-2 cell line from Ryukin goldfish fin tissue, which proved susceptible to CyHV-2 and facilitated the first attenuated vaccine development [48, 50]. Subsequently, the Fantail Goldfish Fin (FtGF) cell line was developed using a non-lethal fin biopsy protocol. FtGF cells have been critical for high-titer virus propagation, achieving (10^{7.8 \pm 0.26}) TCID(_{50})/mL, which is essential for producing standardized viral inocula for challenge studies and vaccine preparation [1, 3, 10]. This cell line allowed for the continuous propagation of CyHV-2 over 20 passages, and the infectivity of the cell culture-derived virus was confirmed by experimental infection of naïve goldfish, which resulted in 100% mortality [10].
The permissiveness of different goldfish tissues has been systematically explored. Three new cell lines from the gill (FtGG), liver (FtGL), and brain (FtGB) of fantail goldfish were established. While all three supported CyHV-2 replication and displayed typical CPE (rounding, detachment, and monolayer destruction) between 3-10 days post-infection, the FtGG cell line demonstrated the highest sensitivity, reaching a viral titer of (10^{7.38}) TCID({50})/mL, significantly higher than FtGL ((10^{4.55})) and FtGB ((10^{6.45})) lines [53]. This suggests that gill-derived cells may be particularly efficient for primary virus isolation and propagation. For gibel carp, the GiCF cell line, derived from caudal fin tissue, has become the standard in vitro model. GiCF cells sustain viral titers of (\sim 10^{4.9}) TCID({50})/mL and have been instrumental in studying viral pathogenesis, including the induction of apoptosis [43], miRNA profiling [56], and the efficacy of antiviral compounds like lauric acid and glycerol monolaurate [54]. The host range of CyHV-2 has also been tested in cell lines from other species. For example, the virus has been shown to replicate in fathead minnow (FHM) cells, a cell line used for the neutralization assays with MAbs against ORF25 [29].
The cytopathic effect (CPE) itself serves as a critical diagnostic indicator. In permissive cell lines, CyHV-2 typically induces a characteristic CPE by 2-5 days post-inoculation, marked by focal areas of cell rounding, syncytia formation (cell fusion), and eventual complete lysis of the monolayer [10, 43, 53]. A key diagnostic nuance involves the detection of persistent or latent virus in asymptomatic carriers. While viral DNA may be amplified by PCR from such fish, the presence of infectious virus is not always guaranteed. Studies have shown that homogenates from PCR-positive tissues of asymptomatic survivors do not always induce CPE or mortality in naïve fish, indicating the presence of non-infectious viral genomes or a state of latency [28]. However, in vitro culture of PCR-positive kidney tissue for 5 days allowed for the detection of infectious particles, suggesting that a brief culture step can reactivate latent virus and enhance diagnostic sensitivity [17]. This concept is further supported by the establishment of a latently infected cell line (GCBLat1) from the brain of CyHV-2-exposed fish. This cell line harbors the CyHV-2 genome but does not produce infectious virions under standard culture conditions. Only upon treatment with chemical inducers like trichostatin A (TSA) or phorbol 12-myristate 13-acetate (TPA) does the virus reactivate, demonstrating a true latent state in vitro [28]. This underscores that cell culture, particularly when combined with activation stimuli, remains the only definitive method for confirming the presence of replication-competent, infectious virus, a critical distinction from merely detecting viral nucleic acid. The integration of these three diagnostic pillars, molecular detection for rapid screening and quantification, serological analysis for exposure history and immune status, and cell culture for definitive isolation and functional studies, provides the comprehensive framework necessary for effective CyHV-2 surveillance, outbreak management, and the advancement of prophylactic and therapeutic strategies.
Immune Response and Vaccine Development Strategies for CyHV-2 Infection
The control of herpesviral hematopoietic necrosis disease (HVHND) caused by cyprinid herpesvirus 2 (CyHV-2) hinges upon a sophisticated understanding of host-pathogen interactions and the development of effective prophylactic interventions. Given the severe economic losses inflicted upon goldfish (Carassius auratus), crucian carp (Carassius carassius), and gibel carp (Carassius auratus gibelio) aquaculture globally, the immunological mechanisms underpinning protection and the diverse vaccine platforms under investigation represent a critical frontier in aquatic veterinary medicine. The immune response to CyHV-2 is complex, involving both innate and adaptive arms, with the virus itself employing a suite of sophisticated immune evasion strategies that challenge vaccine design.
Innate and Adaptive Immune Mechanisms Against CyHV-2
Upon infection, the host innate immune system constitutes the first line of defense. Transcriptomic and proteomic analyses of CyHV-2-infected gibel carp have elucidated a profound perturbation of host signaling pathways. A study by Fei et al. [23] demonstrated that CyHV-2 infection in GiCF cells activates the PI3K-AKT pathway while suppressing the p53 signaling pathway, suggesting a viral strategy to inhibit apoptosis and promote cellular survival for replication. Concurrently, the RIG-I-like receptor (RLR) signaling pathway is activated, as evidenced by the upregulation of RIG-I, MDA5, and LGP2 in the head kidney of infected crucian carp [27]. This activation leads to the induction of type I interferons (IFNs), which are central antiviral effectors. The critical importance of the IFN response is underscored by the virus’s own countermeasures. The CyHV-2 open reading frame 67 (ORF67) has been shown to competitively obstruct STING phosphorylation, a key adaptor in the cytosolic DNA sensing pathway, thereby inhibiting IFN expression and facilitating immune evasion [12]. This molecular antagonism highlights a crucial battleground within the host cell.
The adaptive immune response is indispensable for long-term protection and vaccine efficacy. Following experimental infection or vaccination, a coordinated response involving both cellular and humoral components is mounted. Peripheral blood leukocytes (PBLs) from CyHV-2-sensitized goldfish, when co-cultured with virus-infected cells, exhibit a significant increase in CD8α, IFN-γ, and MHC class I expression, confirming the generation of cytotoxic T lymphocyte (CTL) responses [58]. This cellular immunity is critical for clearing virus-infected cells. In live attenuated vaccine models using the P7-P8 strain, CD8α-positive lymphocytes were found to play a more prominent role in protection than CD4-1-positive cells, leading to a robust secondary cell-mediated immune response [45]. In contrast, fish that survived primary infection through a non-permissive high-temperature treatment relied more heavily on CD4-1-positive lymphocytes and humoral immunity for protection against re-challenge [45]. This dichotomy demonstrates that the nature of the initial antigen encounter, whether with a live, replicating attenuated virus or a non-replicating viral antigen, shapes the dominant protective immune pathway.
Humoral immunity, mediated by specific IgM antibodies, also contributes to protection. A significant increase in anti-CyHV-2 antibody titers was detected by ELISA in gibel carp vaccinated via immersion or injection with the attenuated G-RP7 strain, correlating with high protection rates [50]. Similarly, DNA vaccines based on the ORF25 membrane protein induced specific antibody production in hybridized Prussian carps, contributing to an immunoprotective rate of 70% [38]. However, the level of neutralizing antibodies is not always a direct correlate of protection, as evidenced by the live attenuated P7-P8 vaccine, where high efficacy was observed without a dramatic rise in antibody titers post-challenge, suggesting that cell-mediated immunity is the primary driver of protection in that model [45, 48].
Vaccine Development Strategies: From Inactivated to Recombinant Platforms
The urgent need for a commercial vaccine has driven the exploration of multiple platforms, each with distinct advantages and challenges. These range from traditional inactivated whole-virus vaccines to sophisticated recombinant and live attenuated approaches.
Inactivated Whole-Virus Vaccines represent a safe and straightforward approach, as they cannot revert to virulence. A heat-inactivated CyHV-2 vaccine (80°C for 1 hour) administered intraperitoneally to goldfish resulted in a significant upregulation of immune genes (IL-12, IFN-γ, CD8, CD4) in the kidney and spleen, culminating in a relative percent survival (RPS) of 83.34% after virulent challenge [1]. A parallel study using a formalin-inactivated (0.1%) CyHV-2 vaccine achieved an RPS of 74.03%, also inducing a robust adaptive gene expression profile [3]. While these results are promising, the requirement for large-scale virus propagation and the relatively lower immunogenicity compared to live vaccines, often necessitating adjuvants or multiple doses, remain barriers to commercial uptake.
Live Attenuated Vaccines are arguably the most potent, as they mimic natural infection without causing disease, inducing robust and durable immunity. The attenuated strain G-RP7, generated through serial passage in RyuF-2 and GiCF cell lines, demonstrated exceptional efficacy, with protection rates of 92% by immersion and 100% by intraperitoneal injection in gibel carp, coupled with stable attenuation over six in vivo passages [50]. The P7-P8 strain has also shown high efficacy across a broad temperature range (15–30°C), with an RPS of 100% at 25°C, and protection was correlated with a vaccine virus load exceeding 10⁴ DNA copies/mg in the spleen [48]. A key advantage of this platform is the ability to administer it via immersion, which is practical for vaccinating large numbers of fry. However, the potential for reversion to virulence and the need for strict cold chain logistics are significant regulatory and practical hurdles. Researchers have also explored gene-deleted mutants, such as the ORF55/ORF57 deletion mutants (CyHV-2-Δ55-CP and CyHV-2-Δ57-CP), which show reduced virulence in vivo while retaining replicative capacity in vitro, and can even serve as vectors for foreign antigens, such as the capsid protein of nervous necrosis virus [57].
Submit and DNA Vaccines offer enhanced safety profiles by using only specific immunogenic components. Through a comprehensive proteomic analysis of the CyHV-2 virion, eight major immunogenic proteins were identified, including pORF25, pORF57, pORF66, pORF92, pORF115, and pORF132 [37]. These proteins serve as prime targets for subunit vaccine development. A DNA vaccine based on the ORF25 gene successfully induced specific antibodies and upregulated MHC I, IL-1β, and C3 in the kidney, achieving an RPS of 70% in hybridized Prussian carps [38]. Recombinant baculovirus displaying truncated CyHV-2 membrane glycoproteins (including ORF25, ORF25C, and ORF146) were used for immersion immunization of gibel carp, yielding RPS values of 83.3%, 87.5%, and 70.8%, respectively [42]. This demonstrates the potential for baculovirus as a safe and effective delivery vector for immersion vaccination.
Oral and Yeast-Based Vaccines are highly desirable for aquaculture due to their ease of administration, lack of stress on fish, and suitability for mass vaccination. An oral vaccine using Saccharomyces cerevisiae displaying the CyHV-2 ORF132 protein on its surface successfully evoked innate and adaptive immune responses in both mucosal and systemic tissues of crucian carp, leading to an RPS of 64% [52]. Further refinement by Dong et al. [46], using a booster vaccination regimen (initial oral vaccination followed by a boost two weeks later), elevated the RPS to 66.7% in gibel carp and elicited stronger immune-related enzyme activities and gene expression. The yeast cell wall acts as a natural adjuvant and protects the antigen from degradation in the gut, making this platform particularly promising for commercial application. The regulatory approval for such a product remains a key milestone.
Emerging Adjuvants and Antiviral Strategies are also being explored to enhance vaccine efficacy or provide direct protection. Medium-chain fatty acids like lauric acid (LA) and its monoglyceride glycerol monolaurate (GML) have demonstrated direct anti-CyHV-2 activity in vitro by reducing viral copy numbers and cytopathic effects [54]. In vivo, GML administration significantly increased survival rates in CyHV-2-infected goldfish and modulated the host immune response by downregulating pro-inflammatory cytokines (IL-1β, IL-6, TNF-α) while upregulating the anti-inflammatory IL-10 early in infection [54]. Furthermore, plant-derived compounds such as berberine hydrochloride (BBH) and quercetin from star anise extracts have shown dose-dependent antiviral effects against CyHV-2 both in vitro and in vivo, inhibiting viral replication and reducing pathogenesis [51, 55]. These compounds could potentially be integrated into feed as prophylactic or therapeutic agents, complementing vaccination programs.
The path to a licensed CyHV-2 vaccine is multifaceted. While live attenuated vaccines offer the highest efficacy, safety concerns regarding latency and reversion persist. Inactivated and subunit vaccines are safer but require adjuvants and often multiple doses. The oral yeast-based platform stands out for its practicality and cost-effectiveness, but its efficacy (RPS of ~64-67%) needs further optimization, potentially through the inclusion of multiple antigens or more potent immunostimulants. The World Organisation for Animal Health (WOAH) recognizes CyHV-2 as a significant pathogen, and the development of a safe, effective, and commercially viable vaccine is a global priority for the ornamental and food fish industries. Future research should focus on large-scale field trials, the development of DIVA (Differentiating Infected from Vaccinated Animals) strategies, and comprehensive risk assessments to overcome the final hurdles to commercialization.
Prevention, Control, and Biosecurity Measures for Cyprinid Herpesvirus 2
Overview of Prevention and Control Strategies
The management of Cyprinid herpesvirus 2 (CyHV-2) presents a formidable challenge to global aquaculture and ornamental fish industries, given the virus's capacity for latent infection, environmental persistence, and broad host range within the Carassius genus [7, 17, 28]. Unlike many viral pathogens of fish for which robust prophylactic measures exist, the control of herpesviral hematopoietic necrosis disease (HVHND) has historically been hampered by a lack of licensed commercial vaccines, the propensity for subclinical carrier states, and the difficulty of implementing strict biosecurity in open aquaculture systems [1, 3, 35]. The World Organisation for Animal Health (WOAH) classifies CyHV-2 as a significant pathogen of cyprinids, and control strategies must be multi-faceted, integrating vaccination, antiviral therapeutics, genetic selection for resistance, comprehensive biosecurity protocols, and rapid point-of-care diagnostics. The biological complexity of CyHV-2, particularly its ability to establish latency in monocytes and macrophages and reactivate under immunosuppressive conditions, necessitates a nuanced approach that targets both the acute lytic phase of infection and the latent reservoir [7, 17, 28].
Vaccination Strategies: A Cornerstone of Prophylaxis
Inactivated Vaccines: Heat and Formalin Approaches
The development of inactivated vaccines against CyHV-2 has yielded promising results, offering a safe and stable platform for immunization. Dharmaratnam et al. [1] demonstrated that a heat-inactivated CyHV-2 vaccine, prepared by treating viral inoculum (107.8 TCID50/mL) at 80°C for one hour, induced significant upregulation of key immune genes, including IL-12, IL-10, IFN-γ, CD8, and CD4, in the kidney and spleen of immunized goldfish. The single intraperitoneal dose of 300 μL conferred a relative percent survival (RPS) of 83.34% upon challenge with virulent CyHV-2, with the vaccinated group achieving 86.7% survival compared to only 20% in the control group [1]. This study underscores that even a single dose of inactivated virus can elicit a robust, Th1-biased cell-mediated immune response, which is critical for controlling an intracellular pathogen like CyHV-2.
Similarly, formalin-inactivated vaccines have demonstrated substantial protective efficacy. Dharmaratnam et al. [3] used 0.1% formalin for two days to inactivate CyHV-2, and intraperitoneal immunization of goldfish with 300 μL of this preparation resulted in significant upregulation of CD8 and IFN-γ as early as 6 hours post-vaccination. The formalin-inactivated vaccine achieved an RPS of 74.03% against a lethal challenge [3]. These inactivated platforms are attractive for commercial development due to their safety profile, eliminating any risk of reversion to virulence, and their relative ease of production. However, the requirement for intraperitoneal injection is a significant logistical barrier for mass vaccination in large aquaculture operations, necessitating the development of immersion or oral formulations for these killed antigens.
Live Attenuated Vaccines: Superior Efficacy and Immune Mechanisms
Live attenuated vaccines represent the most advanced and efficacious prophylactic strategy against CyHV-2, primarily due to their ability to stimulate both humoral and cell-mediated immunity in a manner that closely mimics natural infection without causing clinical disease. The P7-P8 strain, derived by serial passage of CyHV-2 on RyuF-2 cells, has emerged as a leading candidate. Saito et al. [45] demonstrated that P7-P8 vaccination in goldfish and isogenic ginbuna (Carassius auratus langsdorfii) induced a relative percentage survival exceeding 88% against virulent virus challenge. Critically, this study elucidated the immunological mechanism: P7-P8 vaccination predominantly activated CD8α-positive lymphocytes, indicating a strong and protective cell-mediated immune response, with only modest increases in humoral antibody titers [45]. This contrasts with the immunity induced by virus non-permissive high-temperature water treatment, which relies more heavily on CD4-1 positive lymphocytes [45]. The implication is that live attenuated vaccines drive a cytotoxic T lymphocyte (CTL) response, which is essential for clearing virus-infected cells and establishing long-term memory.
The temperature profile of the P7-P8 vaccine is particularly relevant for field application. Saito et al. [48] showed that the vaccine strain grows effectively between 15°C and 30°C in vitro, and protective efficacy in goldfish was 73.3% at 15°C, 77.8% at 20°C, 100% at 25°C, and 77.8% at 30°C. Notably, the vaccine virus load in the spleen was lowest at 15°C (103.7 DNA copies/mg) and highest at 25°C (106.5 DNA copies/mg), leading to the conclusion that a threshold of approximately 104 DNA copies/mg in the spleen is sufficient to elicit protective acquired immunity [48]. This broad temperature range for efficacy is crucial for temperate aquaculture systems where water temperatures fluctuate seasonally.
Sun et al. [50] developed another attenuated strain, G-RP7, by subculturing CyHV-2 on RyuF-2 and GiCF cells. This strain showed no clinical symptoms in gibel carp following either immersion or intraperitoneal injection, with protection rates of 92% and 100%, respectively. The G-RP7 strain demonstrated remarkable genetic stability; after six serial in vivo passages in gibel carp, no virulence reversion was observed, and viral DNA copies remained at low, stable levels [50]. Furthermore, anti-virus antibody titers were detected by ELISA at 21 days post-vaccination, confirming a robust adaptive immune response [50]. The ability to administer the G-RP7 vaccine via immersion, a non-invasive, scalable method, represents a paradigm shift in CyHV-2 control, making mass vaccination of fry and fingerlings logistically and economically feasible.
Recombinant and Subunit Vaccines: Rational Design and Targeted Immunity
The elucidation of the CyHV-2 proteome and the identification of immunogenic structural proteins have enabled the rational design of recombinant and subunit vaccines. Gao et al. [37] identified eight major immunogenic proteins of CyHV-2, pORF92, pORF115, pORF25, pORF57, pORF66, pORF72, pORF131, and pORF132, by mass spectrometry and Western blotting. Among these, the ORF25 membrane protein has been extensively investigated as a vaccine antigen. Yuan et al. [38] constructed a DNA vaccine, pEGFP-N1-ORF25, based on the ORF25 gene, which induced production of specific antibodies in hybridized Prussian carps and upregulated MHC I, IL-1β, C3, and TF-A expression in the kidneys. The immunoprotective rate reached 70% against CyHV-2 challenge [38]. This demonstrates that a single viral antigen, when delivered in a DNA vaccine platform, can provide substantial protection, likely through both humoral and cellular mechanisms.
Cao et al. [42] employed a baculovirus surface display system to express nine truncated CyHV-2 membrane glycoproteins (including ORF25, ORF25C, and ORF146) and administered them via immersion. This approach yielded RPS values of 83.3%, 87.5%, and 70.8% for ORF25, ORF25C, and ORF146, respectively [42]. The immersion delivery method, combined with the safety of a non-replicating baculovirus vector, offers a practical route for mass immunization. Wang et al. [52] developed an oral vaccine by displaying ORF132 on the surface of Saccharomyces cerevisiae (EBY100/pYD1-ORF132). This yeast-based oral vaccine induced strong innate and adaptive immune responses in both mucosal and systemic tissues of crucian carp, with an RPS of 64% [52]. The oral route is particularly advantageous for aquaculture, as it eliminates the stress of handling and injection, and yeast-based delivery platforms are cost-effective and heat-stable.
The development of recombinant attenuated vaccines through targeted gene deletion represents a frontier in CyHV-2 vaccinology. Feng et al. [57] generated ORF55/ORF57 deletion mutants (CyHV-2-Δ55-CP and CyHV-2-Δ57-CP) that replicate efficiently in GiCF cells but exhibit reduced virulence in vivo. Notably, CyHV-2-Δ57-CP expressing a chimeric capsid protein of red-spotted grouper nervous necrosis virus (RGNNV-CP) elicited antibody responses in grouper, suggesting that attenuated CyHV-2 mutants can serve as viral vectors for multivalent vaccines [57].
Oral Yeast Vaccines: Mucosal Immunity and Practicality
The gut mucosa represents a major portal of entry for CyHV-2, and oral vaccines that stimulate mucosal immunity offer a strategic advantage. Dong et al. [46] developed an oral yeast vaccine and evaluated the effects of a single versus booster vaccination in gibel carp. The booster vaccination strategy resulted in significantly higher activities of immune-related enzymes and gene expression in both mucosal and systemic tissues, culminating in an RPS of 66.7% [46]. This study highlights the importance of prime-boost regimens for oral vaccines, which may be necessary to overcome oral tolerance and achieve robust, durable protection.
Antiviral Therapeutics and Nutraceutical Interventions
Plant-Derived Antivirals: Berberine and Star Anise Extracts
The search for safe, environmentally friendly antiviral compounds has led to the evaluation of plant-derived alkaloids and extracts. Su et al. [55] demonstrated that berberine hydrochloride (BBH), a bioactive alkaloid from Coptis chinensis, systematically impedes CyHV-2 gene transcription and suppresses viral replication in RyuF-2 cells in a dose-dependent manner. In vivo, BBH protected crucian carp from CyHV-2 infection, as evidenced by suppressed viral replication, reduced histopathological lesions, and higher survival rates [55]. Pharmacokinetic analysis revealed rapid absorption (Tmax of 1.5 hours), a suitable plasma half-life (t1/2z of 7-12 hours), and dose-dependent drug exposure following oral administration, supporting its potential as an oral therapeutic [55].
Li et al. [51] investigated the anti-CyHV-2 effects of star anise (Illicium verum) aqueous extract, identifying quercetin as a major active component that inhibits viral replication by suppressing phosphorylation of AKT in the PI3K/AKT signaling pathway. Of 14 key compounds evaluated in star anise, nine exhibited antiviral effects in vitro. The standardized aqueous extract demonstrated significant anti-CyHV-2 activity both in vitro and in vivo, with quercetin pharmacokinetics characterized in the liver, kidney, and blood [51]. This study provides a theoretical basis for the development of star anise-based green therapeutics for aquaculture.
Medium-Chain Fatty Acids: Lauric Acid and Glycerol Monolaurate
Zhang et al. [54] systematically evaluated the anti-CyHV-2 effects of lauric acid (LA) and glycerol monolaurate (GML), medium-chain fatty acid derivatives with known antiviral and immunomodulatory properties. In vitro, both LA and GML significantly reduced viral copy numbers in GiCF cells, attenuated cytopathic effects, and suppressed intracellular viral replication. Transcriptomic analysis revealed that LA and GML induced widespread alterations in host signaling pathways, including steroid biosynthesis, ECM-receptor interaction, and cell survival pathways, with significant upregulation of insr, akt2, pdk1, lamtor3, and hsp90b [54].
The in vivo protective efficacy of GML was particularly impressive. In CyHV-2-infected goldfish, GML administration significantly increased survival rate and mitigated histopathological damage in the gills, liver, spleen, and kidney [54]. At 3 days post-infection, pro-inflammatory cytokines (IL-1β, IL-6, TNF-α) were significantly lower in the GML-treated group compared to infected controls, while the anti-inflammatory cytokine IL-10 was significantly upregulated. By 7 days post-infection, differences in inflammatory cytokine expression had diminished, suggesting that GML modulates the host immune response during the critical early stage of infection, potentially limiting the immunopathology associated with HVHND [54].
Genetic Selection for Resistance
The identification and exploitation of host genetic resistance to CyHV-2 offers a sustainable, long-term strategy for disease control. Tanaka et al. [44] demonstrated that the resistant trait against HVHN in goldfish exhibits a Mendelian dominant inheritance pattern. Progeny from resistant Azumanishiki parents showed increased resistance to CyHV-2, and a resistant strain of this variety has been established at the Saitama Fisheries Research Institute in Japan [44]. In a series of controlled breeding experiments, F1 hybrids between resistant Azumanishiki and susceptible Kurodemekin varieties were resistant to virus challenge. Subsequent crosses (F2 to F3) and backcrosses confirmed that the resistant trait is dominant and can be introgressed into susceptible lines while retaining desired ornamental phenotypes (e.g., pop-eyed character) [44].
This genetic approach is particularly valuable because it does not rely on continuous administration of vaccines or drugs, reducing production costs and labor. The identification of specific quantitative trait loci (QTL) or major resistance genes associated with HVHN resistance could accelerate marker-assisted selection (MAS) programs, enabling the rapid development of resistant broodstock for the ornamental goldfish industry.
Biosecurity Protocols and Integrated Control Measures
Surveillance and Diagnostic Capacity
Effective biosecurity is predicated on rapid, sensitive, and specific detection of CyHV-2, both in clinically diseased fish and asymptomatic carriers. The development of point-of-care diagnostics has revolutionized field surveillance. Preena et al. [4] developed a recombinase polymerase amplification assay coupled with lateral flow dipsticks (RPA-LFD) targeting the major capsid protein (MCP) gene, achieving detection of 102 gene copies per reaction within 20 minutes at 36°C, with no cross-reactivity to CyHV-3, SVCV, ISKNV, or VNNV. Similarly, Wang et al. [32] developed an RPA-LFD assay targeting the ORF72 gene that is 100 times more sensitive than conventional PCR and requires only 15 minutes at 38°C. Hou et al. [15] integrated recombinase-aided amplification (RAA) with the CRISPR/Cas12a system in a one-pot reaction, enabling detection of as few as 10 copies per reaction within 60 minutes, with higher positive detection rates in clinical samples than traditional PCR.
For water-based surveillance, Hou et al. [15] also demonstrated that the RAA-CRISPR/Cas12a method can be combined with iron flocculation technology to concentrate virus from aquaculture water samples, enabling non-lethal environmental monitoring. This approach minimizes the need for fish dissection, maximizing animal welfare and detection efficiency [15]. The LAMP-LFD method developed by Li et al. [26] offers detection at 64°C within 60 minutes with a limit of 0.18 pg/μL of DNA, requiring only a simple water bath. These advanced molecular tools, combined with the monoclonal antibody-based immunodiagnostic methods developed by Zhao et al. [20] and others, provide a comprehensive diagnostic toolkit for both nucleic acid and antigen detection in field settings.
Quarantine and Disinfection Protocols
The introduction of CyHV-2 into naïve populations most frequently occurs through the movement of infected but clinically healthy fish. Panicz et al. [18] identified asymptomatic common carp (Cyprinus carpio) as carriers of CyHV-2 in cage culture, while Bergmann et al
References
[1] Dharmaratnam A, Sudhagar A, Swaminathan TR. Evaluation of protective effects of heat-inactivated cyprinid herpesvirus-2 (CyHV-2) vaccine against herpesviral hematopoietic necrosis disease (HVHND) in goldfish (Carassius auratus).. Fish and Shellfish Immunology. 2022. DOI: https://doi.org/10.1016/j.fsi.2022.108460
[2] Jung M, Ryu J, Nikapitiya C, Jung S. Detection of herpesviral hematopoietic necrosis virus (Cyprinid herpesvirus 2, CyHV-2) from goldfish, Carassius auratus (L.) in Korea. Fisheries and aquatic sciences. 2022. DOI: https://doi.org/10.47853/fas.2022.e36
[3] Dharmaratnam A, Sudhagar A, Das S, Nair RR, Nithianantham SR, Preena PG, et al.. Immune gene expression and protective effects in goldfish (Carassius auratus L.) immunized with formalin-inactivated cyprinid herpesvirus-2 (CyHV-2) vaccine.. Microbial Pathogenesis. 2022. DOI: https://doi.org/10.1016/j.micpath.2022.105452
[4] Preena PG, Kumar TVA, Johny TK, Dharmaratnam A, Swaminathan TR. Quick hassle-free detection of cyprinid herpesvirus 2 (CyHV-2) in goldfish using recombinase polymerase amplification-lateral flow dipstick (RPA-LFD) assay. Aquaculture International. 2022. DOI: https://doi.org/10.1007/s10499-021-00806-2
[5] Malla S, Saha H, Ghosh L. Pathogenicity and molecular characterization of cyprinid herpesvirus-2 (CyHV-2) infecting Hypophthalmichthys molitrix in India. Journal of Fisheries. 2026. DOI: https://doi.org/10.17017/j.fish.1196
[6] Wen J, Xu Y, Su M, Lu L, Wang H. Susceptibility of Goldfish to Cyprinid Herpesvirus 2 (CyHV-2) SH01 Isolated from Cultured Crucian Carp. Viruses. 2021. DOI: https://doi.org/10.3390/v13091761
[7] Chang W, Kakazu T, Chuah Q, Tanaka M, Kato G, Sano M. Reactivation of cyprinid herpesvirus 2 (CyHV-2) in asymptomatic surviving goldfish Carassius auratus (L.) under immunosuppression.. Fish and Shellfish Immunology. 2020. DOI: https://doi.org/10.1016/j.fsi.2020.05.020
[8] Yang J, Wen J, Xiao S, Wei C, Yu F, Roengjit P, et al.. Complete Genome and Molecular Characterization of a New Cyprinid Herpesvirus 2 (CyHV-2) SH-01 Strain Isolated from Cultured Crucian Carp. Viruses. 2022. DOI: https://doi.org/10.3390/v14092068
[9] Radosavljevic V, Maksimović-Zorić J, Veljović L, Ljubojević D, Ćirković M, Markovic Z, et al.. CYPRINID HERPESVIRUS DISEASES. Archives of Veterinary Medicine. 2019. DOI: https://doi.org/10.46784/e-avm.v10i1.81
[10] Dharmaratnam A, Kumar R, Valaparambil BS, Sood N, Pradhan PK, Das S, et al.. Establishment and characterization of fantail goldfish fin (FtGF) cell line from goldfish, Carassius auratus for in vitro propagation of Cyprinid herpes virus-2 (CyHV-2). PeerJ. 2020. DOI: https://doi.org/10.7717/peerj.9373
[11] Jiang N, Yuan D, Zhang M, Luo L, Wang N, Xing W, et al.. Diagnostic case report: Disease outbreak induced by CyHV-2 in goldfish in China. Aquaculture. 2020. DOI: https://doi.org/10.1016/j.aquaculture.2020.735156
[12] Cui B, Zhang C, Zhou C, Li Z, Xu X, Wang Y, et al.. Cyprinid herpesvirus 2 (CyHV-2) ORF67 inhibits IFN expression by competitively obstructing STING phosphorylation.. Fish and Shellfish Immunology. 2025. DOI: https://doi.org/10.1016/j.fsi.2025.110372
[13] Xu C, Yu F, Xue M, Huang Z, Jiang N, Li Y, et al.. Proteogenomic analysis of Cyprinid herpesvirus 2 using high-resolution mass spectrometry. Journal of Virology. 2025. DOI: https://doi.org/10.1128/jvi.01960-24
[14] Yang J, Xiao S, Lu L, Wang H, Jiang Y. Genomic and molecular characterization of a cyprinid herpesvirus 2 YC-01 strain isolated from gibel carp. Heliyon. 2024. DOI: https://doi.org/10.1016/j.heliyon.2024.e32811
[15] Hou Z, Ding Z, Zhang Y, Pang B, Gui L, Liu Y, et al.. Establishment and Application of a Rapid Detection Method of Cyprinid Herpesvirus 2 (CyHV-2) in Aquacultural Waters by Using a Novel One-Pot RAA-CRISPR/Cas12a Combined With Fe-Iron Flocculation Technology.. Journal of Fish Diseases. 2025. DOI: https://doi.org/10.1111/jfd.14089
[16] Fu Y, Zhang J, Cheng W, Cheng X, Lu L, Gui L, et al.. miR-124 mediates the expression of ccBax to regulate Cyprinid herpesvirus 2 (CyHV-2)-induced apoptosis and viral replication.. Journal of Fish Diseases. 2023. DOI: https://doi.org/10.1111/jfd.13783
[17] Wei C, Iida H, Chuah Q, Tanaka M, Kato G, Sano M. Persistence of cyprinid herpesvirus 2 in asymptomatic goldfish Carassius auratus (L.) that survived an experimental infection.. Journal of Fish Diseases. 2019. DOI: https://doi.org/10.1111/jfd.12996
[18] Panicz R, Sadowski J, Eljasik P. Detection of Cyprinid herpesvirus 2 (CyHV-2) in symptomatic ornamental types of goldfish (Carassius auratus) and asymptomatic common carp (Cyprinus carpio) reared in warm-water cage culture. Aquaculture. 2019. DOI: https://doi.org/10.1016/J.AQUACULTURE.2019.01.065
[19] Xu C, Li Y, Xiao Z, Yang J, Xue M, Jiang N, et al.. Proteomic and Phosphoproteomic Analyses Reveal Gibel Carp Responses to Cyprinid Herpesvirus 2 Infection.. Journal of Proteome Research. 2022. DOI: https://doi.org/10.1021/acs.jproteome.2c00253
[20] Zhao L, Gao W, Zheng Y, Lu L, Li Q, Jiang Y. Development and characterization of monoclonal antibodies specific for cyprinid herpesvirus 2.. Journal of Fish Diseases. 2022. DOI: https://doi.org/10.1111/jfd.13689
[21] Jeong Y, Jeon Y, Choi HJ, Baek E, Kim G, Yang Y, et al.. Genetic characterization of alloherpesvirus (cyprinid herpesvirus-2 and koi herpesvirus) and poxvirus (carp edema virus) identified from domestic and imported cyprinids in Korea. Fisheries and aquatic sciences. 2023. DOI: https://doi.org/10.47853/fas.2023.e36
[22] Guo B, Wei C, Luan L, Zhang J, Li Q. Production and application of monoclonal antibodies against ORF66 of cyprinid herpesvirus 2.. Journal of Virological Methods. 2021. DOI: https://doi.org/10.1016/j.jviromet.2021.114342
[23] Fei Y, Han M, Chu X, Feng Z, Yu L, Luo Y, et al.. Transcriptomic and proteomic analyses reveal new insights into the regulation of immune pathways during cyprinid herpesvirus 2 infection in vitro.. Fish and Shellfish Immunology. 2020. DOI: https://doi.org/10.1016/j.fsi.2020.07.044
[24] Lu J, Jin T, Zhou T, Lu X, Chen J, Chen J. Identification and characterization of a tumor necrosis factor receptor like protein encoded by Cyprinid Herpesvirus 2.. Developmental and Comparative Immunology. 2020. DOI: https://doi.org/10.1016/j.dci.2020.103930
[25] Zhang T, Yuan R, Zhang X, Liu B, Zhou Y, Liang Z, et al.. De novo RNA-seq assembly and differential transcriptome analysis of Carassius auratus gibelio after Cyprinid herpesvirus 2 infection. Aquaculture. 2020. DOI: https://doi.org/10.1016/j.aquaculture.2020.734923
[26] Li Y, Lin F, Sun L, Huang A, Chen J, Hao G, et al.. Detection of cyprinid herpesvirus 2 by loop-mediated isothermal amplification in combination with a lateral flow dipstick.. Molecular and Cellular Probes. 2020. DOI: https://doi.org/10.1016/j.mcp.2020.101507
[27] Liu M, Wu T, Li S, Wei P, Yan Y, Gu W, et al.. Combined transcriptomic/proteomic analysis of crucian carp Carassius auratus gibelio in cyprinid herpesvirus 2 infection. Fish and Shellfish Immunology. 2018. DOI: https://doi.org/10.1016/j.fsi.2018.07.057
[28] Chai W, Qi L, Zhang Y, Hong M, Jin L, Li L, et al.. Evaluation of Cyprinid Herpesvirus 2 Latency and Reactivation in Carassius gibel. Microorganisms. 2020. DOI: https://doi.org/10.3390/microorganisms8030445
[29] Wu R, Zhang Q, Li Y. Development, characterization of monoclonal antibodies specific for the ORF25 membrane protein of Cyprinid herpesvirus 2 and their applications in immunodiagnosis and neutralization of virus infection. Aquaculture. 2020. DOI: https://doi.org/10.1016/j.aquaculture.2019.734904
[30] Shen Z, Jiang Y, Lu J, Sano M, Xu D, Lu L. Application of a monoclonal antibody specific for the ORF92 capsid protein of Cyprinid herpesvirus 2.. Journal of Virological Methods. 2018. DOI: https://doi.org/10.1016/j.jviromet.2018.07.012
[31] Zhao R, Geng Y, Yu Z, Wang K, Ouyang P, Chen D, et al.. New detection of Cyprinid herpesvirus 2 associated with mass mortality in colour crucian carp ( Carassius auratus ), in China. Aquaculture Research. 2019. DOI: https://doi.org/10.1111/ARE.14054
[32] Wang H, Sun M, Xu D, Podok P, Xie J, Jiang Y, et al.. Rapid visual detection of cyprinid herpesvirus 2 by recombinase polymerase amplification combined with a lateral flow dipstick.. Journal of Fish Diseases. 2018. DOI: https://doi.org/10.1111/jfd.12808
[33] Wang F, Xu Y, Zhou Y, Ding C, Duan H. Isolation and characterization of a Cyprinid herpesvirus strain YZ01 from apparently healthy goldfish after rising water temperature. bioRxiv. 2021. DOI: https://doi.org/10.1101/2021.07.05.451087
[34] Dharmaratnam A, Kumar R, Pradeep M, Sood N, Swaminathan TR. Development and comparison of loop mediated isothermal amplification assay and polymerase chain reaction based on major capsid protein gene for detection of CyHV-2 infection in goldfish Carassius auratus (L.). Indian Journal of Fisheries. 2024. DOI: https://doi.org/10.21077/ijf.2024.71.2.127966-11
[35] Bergmann S, Wang Y, Li Y, Wang Q, Klafack S, Jin Y, et al.. Occurrence of herpesvirus in fish. Journal of Veterinary Research. 2024. DOI: https://doi.org/10.2478/jvetres-2024-0008
[36] Abraham T, David M, Patra A, Banerjee S, Adikesavalu H. Surveillance of herpesviruses in koi carp Cyprinus carpio koi and goldfish Carassius auratus cultured in West Bengal, India. Journal of Exotic Pet Medicine. 2020. DOI: https://doi.org/10.1053/j.jepm.2019.12.004
[37] Gao W, Wen H, Wang H, Lu J, Lu L, Jiang Y. Identification of structure proteins of cyprinid herpesvirus 2. Aquaculture. 2020. DOI: https://doi.org/10.1016/j.aquaculture.2020.735184
[38] Yuan X, Shen J, Pan X, Yao J, Lyu S, Liu L. Screening for protective antigens of Cyprinid herpesvirus 2 and construction of DNA vaccines.. Journal of Virological Methods. 2020. DOI: https://doi.org/10.1016/j.jviromet.2020.113877
[39] Gao W, Zhao L, Zheng Y, Wu K, Xu F, Wang H, et al.. Generation and application of a monoclonal antibody specific for the ORF121 of cyprinid herpesvirus 2.. Journal of Fish Diseases. 2021. DOI: https://doi.org/10.1111/jfd.13566
[40] Luo Y, Yu L, Feng Z, Chen Q, Lu L, Zhang Q, et al.. Integrated analysis of viral miRNAs, mRNA and protein in the caudal fin cells of C. auratus gibelio with cyprinid herpesvirus 2 infection.. Journal of Fish Diseases. 2021. DOI: https://doi.org/10.1111/jfd.13289
[41] Tang R, Lu L, Wang B, Yu J, Wang H. Identification of the Immediate-Early Genes of Cyprinid Herpesvirus 2. Viruses. 2020. DOI: https://doi.org/10.3390/v12090994
[42] Cao Z, Liu S, Nan H, Zhao K, Xu X, Wang G, et al.. Immersion immunization with recombinant baculoviruses displaying cyprinid herpesvirus 2 membrane proteins induced protective immunity in gibel carp.. Fish and Shellfish Immunology. 2019. DOI: https://doi.org/10.1016/j.fsi.2019.08.036
[43] Lu J, Xu D, Lu L. A novel cell line established from caudal fin tissue of Carassius auratus gibelio is susceptible to cyprinid herpesvirus 2 infection with the induction of apoptosis.. Virus Research. 2018. DOI: https://doi.org/10.1016/j.virusres.2018.09.010
[44] Tanaka M, Dairiki K, Nakajima M, Kato G, Sakamoto T, Sano M. Inheritance of the Resistant Trait in Goldfish against Herpesviral Hematopoietic Necrosis. Gyobyo kenkyu - Fish pathology. 2018. DOI: https://doi.org/10.3147/JSFP.53.117
[45] Saito H, Lau L, Minami S, Yuguchi M, Matsumoto M, Nakanishi T, et al.. Cell-mediated and humoral immune responses of cyprinids induced by a live attenuated vaccine against cyprinid herpesvirus 2 infection in comparison to the virus non-permissive high temperature water treatment.. Fish and Shellfish Immunology. 2024. DOI: https://doi.org/10.1016/j.fsi.2024.109991
[46] Dong Z, Mu Q, Kong W, Qin D, Zhou Y, Wang X, et al.. Gut mucosal immune responses and protective efficacy of oral yeast Cyprinid herpesvirus 2 (CyHV-2) vaccine in Carassius auratus gibelio. Frontiers in Immunology. 2022. DOI: https://doi.org/10.3389/fimmu.2022.932722
[47] Ullrich J, Christian J, Bergmann S, Oberle M, Becker A. Stability of viral haemorrhagic septicaemia virus, infectious hematopoietic necrosis virus and cyprinid herpesvirus 3 in various water samples.. Journal of Fish Diseases. 2020. DOI: https://doi.org/10.1111/jfd.13321
[48] Saito H, Minami S, Yuguchi M, Shitara A, Kondo H, Kato G, et al.. Effect of temperature on the protective efficacy of a live attenuated vaccine against herpesviral haematopoietic necrosis in goldfish.. Journal of Fish Diseases. 2023. DOI: https://doi.org/10.1111/jfd.13906
[49] Ahmadivand S, Soltani M, Shokrpoor S, Rahmati-Holasoo H, El-Matbouli M, Taheri-Mirghaed A. Cyprinid herpesvirus 3 (CyHV-3) transmission and outbreaks in Iran: Detection and characterization in farmed common carp.. Microbial Pathogenesis. 2020. DOI: https://doi.org/10.1016/j.micpath.2020.104321
[50] Sun Y, Xu C, Wang H, Qiao G, Wang Z, Li Z, et al.. An attenuated strain of cyprinid herpesvirus 2 as a vaccine candidate against herpesviral hematopoietic necrosis disease in gibel carp, Carassius auratus gibelio.. Fish and Shellfish Immunology. 2023. DOI: https://doi.org/10.1016/j.fsi.2023.108826
[51] Li M, Song Y, Lu L, Wang H. Evaluation of Anti-CyHV-2 Effects of Star Anise (Illicium verum) Aqueous Extract.. Fish and Shellfish Immunology. 2025. DOI: https://doi.org/10.1016/j.fsi.2025.110621
[52] Wang L, Yang M, Luo S, Yang G, Lu X, Lu J, et al.. Oral Vaccination of Recombinant Saccharomyces cerevisiae Expressing ORF132 Induces Protective Immunity against Cyprinid Herpesvirus-2. Vaccines. 2023. DOI: https://doi.org/10.3390/vaccines11010186
[53] Swaminathan T, Raja A, Dharmaratnam A, Nithianantham SR. Comparative sensitivity of three new cell lines developed from gill, liver and brain tissues of goldfish, Carassius auratus (L.) to cyprinid herpesvirus-2 (CyHV-2).. Journal of Virological Methods. 2021. DOI: https://doi.org/10.1016/j.jviromet.2021.114069
[54] Zhang J, Qin Y, Ma M, Xu T, Zhang Y, Gui L, et al.. Lauric Acid and Glycerol Monolaurate Inhibit the Activity of Cyprinid Herpesvirus 2 and Enhance Host Immune Reaction. Journal of Fish Diseases. 2026. DOI: https://doi.org/10.1111/jfd.70174
[55] Su M, Tang R, Wang H, Lu L. Suppression effect of plant-derived berberine on cyprinid herpesvirus 2 proliferation and its pharmacokinetics in Crucian carp (Carassius auratus gibelio).. Antiviral Research. 2020. DOI: https://doi.org/10.1016/j.antiviral.2020.105000
[56] Fei Y, Feng Z, Wu K, Luo Y, Yu L, Zhang Y, et al.. MicroRNA expression profiling of caudal fin cell of C. auratus gibelio upon cyprinid herpesvirus 2 infection.. Developmental and Comparative Immunology. 2020. DOI: https://doi.org/10.1016/j.dci.2020.103637
[57] Feng Z, Cheng W, Ma M, Yu C, Zhang Y, Lu L, et al.. Generation and Characterization of ORF55/ORF57-Deleted Recombinant Cyprinid herpesvirus 2 Mutants with Chimeric Capsid Protein Gene of Grouper Nervous Necrosis Virus. Vaccines. 2023. DOI: https://doi.org/10.3390/vaccines12010043
[58] Das S, Dharmaratnam A, Ravi C, Kumar R, Swaminathan T. Immune gene expression in cyprinid herpesvirus-2 (CyHV-2)–sensitized peripheral blood leukocytes (PBLs) co-cultured with CyHV-2-infected goldfish fin cell line. Aquaculture International. 2021. DOI: https://doi.org/10.1007/s10499-021-00721-6